Special screening examination for neoplasms

Z21_SPECIAL_SCREEN_EXAM_NEOPLASMS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Z12 Cause of death: ICD-10 — Z12 2 out of 7 registries used, show all original rules.	3419
4. Check minimum number of events None	3419
5. Include endpoints None	3419
6. Filter based on genotype QC (FinnGen only)	3061

Control definitions (FinnGen only)

Control exclude: Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_EXAM_INVES

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: Z[0-1]

NAME	Z21_SPECIAL_SCREEN_EXAM_NEOPLASMS
CONTROL_EXCLUDE	Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_EXAM_INVES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Z12
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Z12
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Special screening examination for neoplasms based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3061	1300	1761
Unadjusted period prevalence (%)	0.66	0.46	0.81
Median age at first event (years)	64.30	63.97	64.54

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3151: Matched controls
31510

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Z01.8

ICD-10 Finland

Other specified special examinations

7.3

307.7

593

975

UJF32

NOMESCO Finland

Coloscopy

5.6

307.7

1392

3875

Z12.5

ICD-10 Finland

Special screening examination for neoplasm of prostate

243.5

307.7

814

TKE00

NOMESCO Finland

Needle biopsy of prostate

13.0

307.7

514

464

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

14.0

307.7

824

777

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

8.6

307.7

522

715

UJF30

NOMESCO Finland

Ileoscopy through colon

10.6

307.7

921

1184

Z01.0

ICD-10 Finland

Examination of eyes and vision

11.1

307.7

417

428

Z12.1

ICD-10 Finland

Special screening examination for neoplasm of intestinal tract

912.7

307.7

1895

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

35.0

262.1

166

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

9.1

231.7

297

357

Z12.4

ICD-10 Finland

Special screening examination for neoplasm of cervix

9.7

229.2

278

311

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

5.7

206.5

424

842

Z12.3

ICD-10 Finland

Special screening examination for neoplasm of breast

28.1

187.5

127

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

62.5

175.0

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

15.4

173.3

153

104

Z01.1

ICD-10 Finland

Examination of ears and hearing

6.1

172.4

320

575

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

3.3

170.8

828

3077

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

5.4

165.7

356

732

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

20.9

151.6

115

C61

ICD-10 Finland

Malignant neoplasm of prostate

3.3

128.9

572

1986

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

267.0

126.0

128

XJH00

NOMESCO Finland

Transanal ultrasonography

4.2

123.9

358

930

K63.5

ICD-10 Finland

Polyp of colon

6.2

122.5

216

367

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

3.3

121.5

545

1900

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

12.5

118.7

118

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

12.0

111.3

113

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

136.2

110.9

118

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.5

108.5

878

4165

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

4.8

106.5

254

566

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

3.4

93.4

372

1196

Z71.8

ICD-10 Finland

Other specified counselling

2.2

91.6

1060

5811

Z12.8

ICD-10 Finland

Special screening examination for neoplasms of other sites

893.1

89.2

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

5.3

88.3

183

361

D16

ICPC

Rectal bleeding

6.5

85.8

144

232

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

3.2

75.9

322

1072

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

18.8

74.4

TPH04

NOMESCO Finland

Cathetrisation of vein

2.2

68.4

738

3863

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

4.0

68.0

204

540

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

5.4

66.6

134

257

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

3.0

65.2

304

1067

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

9.3

63.5

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

3.0

63.1

307

1103

K64.0

ICD-10 Finland

First degree haemorrhoids

5.1

62.2

133

269

Z00.0

ICD-10 Finland

General medical examination

2.5

61.3

416

1774

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

6.2

56.5

163

Z01.7

ICD-10 Finland

Laboratory examination

2.2

54.7

511

2503

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

67.8

52.3

N02AX02

ATC

tramadol; systemic, rectal

1.8

51.4

1300

8918

XCK10

NOMESCO Finland

Photography of fundus of eye

3.0

50.8

242

857

Z3231

NOMESCO Finland

Registered nurse

1.9

50.8

772

4518

XKD00

NOMESCO Finland

Uroflowmetry

2.1

49.7

584

3118

Z25.1

ICD-10 Finland

Need for immunization against influenza

3.2

48.2

198

643

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.9

47.9

848

5200

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.1

47.0

506

2610

JFA52

NOMESCO Finland

Other endoscopic haemostatic procedure in colon

13.5

46.8

Z04.3

ICD-10 Finland

Examination and observation following other accident

454.2

45.4

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

5.2

44.8

187

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.6

44.6

278

1132

Z00.8

ICD-10 Finland

Other general examinations

3.2

44.2

184

602

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

44.2

919

5895

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

4.7

44.0

104

229

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

2.3

42.9

376

1783

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

4.9

41.4

196

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

41.4

710

4282

127

Kela drug reimbursment

Transplant complication

7.3

40.7

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.1

40.6

174

579

DFF00

NOMESCO Finland

Pure tone audiometry

2.8

40.0

214

805

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.2

39.6

366

1771

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

3.7

39.4

126

348

XF402

NOMESCO Finland

ECG with work load test

2.4

39.3

284

1237

A02BC02

ATC

pantoprazole; systemic

1.7

39.3

1992

16021

J01DB01

ATC

cefalexin; oral

1.8

38.4

2424

20595

116

Kela drug reimbursment

Prostate cancer

2.5

38.0

250

1042

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

38.0

1340

9813

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

4.5

37.9

215

Z2221

NOMESCO Finland

Medical doctor

1.8

37.7

797

5099

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

37.5

872

5726

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

2.4

36.7

269

1179

N02BE01

ATC

paracetamol; systemic, rectal

1.9

36.5

2666

23416

UKC02

NOMESCO Finland

Cystoscopy

2.0

35.9

473

2606

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.7

35.8

770

4937

Z31.5

ICD-10 Finland

Genetic counselling

3.0

35.8

159

540

XG410

NOMESCO Finland

Flow-volume spirometry

4.0

35.3

102

262

Z12.0

ICD-10 Finland

Special screening examination for neoplasm of stomach

351.1

35.0

J01EA01

ATC

trimethoprim; systemic

1.8

34.5

609

3682

R4110

NOMESCO Finland

Physiotherapy

1.7

34.5

858

5715

R06.0

ICD-10 Finland

Dyspnoea

1.8

34.1

688

4324

Z94.0

ICD-10 Finland

Kidney transplant status

7.8

34.0

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

3.1

33.9

146

487

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

32.7

457

2564

N03AX16

ATC

[U] pregabalin

1.8

32.6

591

3597

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

2.2

32.2

287

1365

R4110, ,

SPAT

2.0

32.2

399

2149

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

3.4

32.2

117

352

J01MA02

ATC

ciprofloxacin; systemic

1.6

32.0

1108

7988

XQ800

NOMESCO Finland

Prick test

3.3

31.9

122

379

Z97.4

ICD-10 Finland

Presence of external hearing-aid

4.0

31.3

235

WX002

NOMESCO Finland

Sedation and analgesia

1.8

31.3

552

3328

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

31.0

1076

7749

XA402

NOMESCO Finland

ENMG

6.3

30.9

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

9.6

30.6

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

4.6

30.6

158

L04AD02

ATC

tacrolimus; systemic

8.0

30.3

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

4.8

29.9

145

M54.5

ICD-10 Finland

Low back pain

1.6

29.6

936

6578

G47.3

ICD-10 Finland

Sleep apnoea

1.7

29.5

696

4544

M25.5

ICD-10 Finland

Pain in joint

1.6

28.9

867

6009

R5110, ,

SPAT

2.3

28.7

235

1078

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

28.6

287

1428

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

28.1

649

4207

Z20.9

ICD-10 Finland

Contact with and exposure to unspecified communicable disease

3.7

28.1

240

R31

ICD-10 Finland

Unspecified haematuria

2.0

28.0

319

1663

XQ802

NOMESCO Finland

Epicutan test

4.7

28.0

141

Z01.2

ICD-10 Finland

Dental examination

1.5

27.9

1221

9205

L28

ICPC

Limited function/disability (L)

1.8

27.8

457

2689

S18

ICPC

Laceration/cut

1.5

27.8

1278

9736

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

28.8

27.6

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

3.5

27.6

281

C07AB07

ATC

bisoprolol; oral

1.5

27.5

1350

10423

FM1LE

NOMESCO Finland

Combined ultrasound and EKG examination of heart with tolerance test

9.3

27.4

L04AA06

ATC

mycophenolic acid; systemic

4.9

27.2

125

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.8

27.1

513

3145

ZX120

NOMESCO Finland

Intravenous

2.2

26.8

245

1176

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

26.7

348

1902

ZXA00

NOMESCO Finland

Right side

1.6

26.2

721

4875

K03.66

ICD-10 Finland

Tooth plaque

2.3

26.1

209

950

A02BC05

ATC

esomeprazole; systemic

1.5

26.0

1072

7951

WVA20

NOMESCO Finland

Medicine administration

3.2

25.8

103

329

XF404

NOMESCO Finland

Ambulatory ECG

2.3

25.7

208

949

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

25.7

713

4830

R42

ICD-10 Finland

Dizziness and giddiness

1.7

25.6

538

3392

Z29.8

ICD-10 Finland

Other specified prophylactic measures

3.2

25.3

102

327

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.1

25.1

263

1329

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

3.6

25.1

230

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

25.0

174

744

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

24.9

1990

16828

WW200, ,

SPAT

1.5

24.8

926

6707

L02AE02

ATC

leuprorelin; implant, parenteral

2.4

24.5

174

750

XCK00

NOMESCO Finland

Perimetry

2.8

24.3

123

449

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

23.7

677

4606

N40

ICD-10 Finland

Hyperplasia of prostate

1.6

23.7

765

5357

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.7

23.6

502

3171

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.7

23.6

133

514

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

3.6

23.6

221

Z49.0

ICD-10 Finland

Preparatory care for dialysis

6.5

23.5

J01AA02

ATC

doxycycline; systemic

1.5

23.2

2258

19712

ZXA05

NOMESCO Finland

Left side

1.6

23.1

657

4462

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.7

23.1

426

2587

L17

ICPC

Foot/toe symptom/complaint

1.6

23.0

753

5283

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

23.0

1188

9170

L02BB03

ATC

bicalutamide; oral

3.0

22.9

105

363

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

22.9

1044

7857

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.2

22.9

197

922

M79.6

ICD-10 Finland

Pain in limb

1.5

22.8

1117

8528

XG466

NOMESCO Finland

Sleep oxymetry

3.2

22.6

287

A98

ICPC

Health maint/preventive medicine

2.0

22.6

2937

27437

B01AB05

ATC

enoxaparin; parenteral

1.5

22.5

824

5920

XG405

NOMESCO Finland

Education on PEF monitoring

6.1

22.5

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

22.3

701

4868

J01FF01

ATC

clindamycin; systemic

1.6

22.1

698

4852

Z49.2

ICD-10 Finland

Other dialysis

7.3

22.0

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

22.0

439

2721

WX722

NOMESCO Finland

PEEP

2.5

22.0

140

574

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.7

22.0

118

445

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.8

21.9

113

417

Z12.9

ICD-10 Finland

Special screening examination for neoplasm, unspecified

63.0

21.9

Z50.1

ICD-10 Finland

Other physical therapy

2.6

21.8

125

487

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

21.8

242

1248

Z71.9

ICD-10 Finland

Counselling, unspecified

2.1

21.6

206

1005

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.8

21.4

110

405

WZA90

NOMESCO Finland

Other medical or dental certificate

1.6

21.4

569

3795

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.8

21.4

385

2319

J01MA12

ATC

levofloxacin; systemic

1.6

21.1

502

3258

C03CA01

ATC

furosemide; systemic

1.5

21.1

734

5207

ZYC01

NOMESCO Finland

Remote contact by phone

2.4

20.9

151

656

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

20.8

391

2382

P01AB01

ATC

metronidazole; oral, rectal

1.5

20.7

1028

7834

M03BX02

ATC

tizanidine; oral

1.4

20.7

1732

14525

R52.9

ICD-10 Finland

Pain, unspecified

2.0

20.5

248

1317

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

8.2

20.5

UJD02

NOMESCO Finland

Gastroscopy

2.6

20.5

120

473

Z3226

NOMESCO Finland

Physiotherapist

1.6

20.4

474

3056

L03

ICPC

Low back symptom/complaint

1.5

20.3

677

4751

R51.80

ICD-10 Finland

Headache

1.8

20.2

295

1667

Z02.7

ICD-10 Finland

Issue of medical certificate

2.2

20.2

176

828

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

2.8

20.2

104

384

J01CA04

ATC

amoxicillin; systemic

1.5

20.1

2264

19990

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

20.1

1794

15178

A28

ICPC

Limited function/disability NOS

1.7

20.1

413

2578

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

4.0

20.0

141

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

8.0

20.0

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

20.0

408

2542

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

20.0

1131

8820

G04BE03

ATC

sildenafil; oral

3.8

19.9

164

K30

ICD-10 Finland

Functional dyspepsia

1.9

19.8

267

1470

N06AX21

ATC

duloxetine; oral

1.9

19.8

257

1398

H02AB06

ATC

prednisolone; systemic

1.4

19.7

1231

9765

WZC00, ,

SPAT

1.7

19.7

404

2519

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.0

19.5

206

1044

K02.1

ICD-10 Finland

Caries of dentine

1.4

19.4

1541

12741

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

19.4

341

2038

N06AX11

ATC

mirtazapine; oral

1.5

19.4

800

5865

H3603, E103,

ICD-10 Finland

8.4

19.3

C08CA01

ATC

amlodipine; oral

1.4

19.2

1080

8395

B05DB

ATC

Hypertonic solutions

6.7

19.1

XA420

NOMESCO Finland

Extensive sleep examination

7.0

19.1

GX1K5

NOMESCO Finland

Diffusion capacity

18.3

19.1

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.3

19.1

153

696

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

18.8

495

3287

R03AC02

ATC

salbutamol; inhalant

1.4

18.7

1381

11249

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.8

18.7

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

5.4

18.5

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

4.6

18.4

R60.0

ICD-10 Finland

Localized oedema

1.8

18.4

297

1730

AA1AD

NOMESCO Finland

CT of head and brain

1.5

18.3

700

5042

B01AF02

ATC

apixaban; oral

1.7

18.3

345

2100

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

16.3

18.3

ULA02

NOMESCO Finland

Kolposcopy

2.0

18.3

194

984

B05DA

ATC

Isotonic solutions

6.1

18.1

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

17.9

280

1614

R53

ICD-10 Finland

Malaise and fatigue

1.6

17.9

529

3603

K55.2

ICD-10 Finland

Angiodysplasia of colon

6.5

17.9

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

26.9

17.8

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

17.8

332

2016

CS494

NOMESCO Finland

Other visual field testing

3.9

17.7

136

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

17.6

226

1224

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.8

17.6

283

1646

M01AH01

ATC

celecoxib; oral

1.6

17.5

454

2998

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.7

17.4

373

N02BF01

ATC

gabapentin; oral

1.9

17.4

241

1339

M70.6

ICD-10 Finland

Trochanteric bursitis

1.8

17.4

300

1782

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

17.3

1898

16429

N03AX12

ATC

[U] gabapentin; oral

1.7

17.3

345

2133

H02AB04

ATC

methylprednisolone; systemic

1.7

17.2

339

2088

Z13.5

ICD-10 Finland

Special screening examination for eye and ear disorders

6.4

17.1

IHA10, ,

SPAT

3.3

17.1

197

G04CA02

ATC

tamsulosin; oral

1.5

17.1

754

5580

E0000UV, ,

ATC

1.4

16.9

1009

7884

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

13.3

16.9

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.1

16.9

168

832

WZC30

NOMESCO Finland

Teaching

1.6

16.9

449

2982

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

16.9

1357

11151

A08

ICPC

Swelling

2.3

16.9

133

601

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

4.4

16.8

E66.01

ICD-10 Finland

Obesity due to excess calories

1.9

16.8

215

1164

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

16.8

913

7018

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

16.7

605

4301

M79.7

ICD-10 Finland

Fibromyalgia

3.3

16.7

195

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

35.2

16.7

137

Kela drug reimbursment

Uraemia requiring dialysis

5.5

16.7

Z00.6

ICD-10 Finland

Examination for normal comparison and control in clinical research programme

6.5

16.6

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

16.6

356

2241

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

3.8

16.6

133

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

16.6

426

2805

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

16.5

264

1534

TQW99

NOMESCO Finland

Other minor procedure on skin

2.2

16.3

131

596

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

16.3

629

4526

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

16.3

295

1775

Y77

ICPC

Malignant neoplasm prostate

2.4

16.3

112

477

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

16.2

460

3101

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

16.2

742

5522

N30.0

ICD-10 Finland

Acute cystitis

1.7

16.2

337

2106

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

16.1

263

1535

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.8

16.1

231

1297

J01FA06

ATC

roxithromycin; oral

1.4

16.1

1025

8085

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

16.1

522

3623

WZC30, ,

SPAT

1.8

16.0

252

1455

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.2

16.0

142

673

JN4AD

NOMESCO Finland

Body CT examination

1.7

16.0

313

1923

D12.7

ICD-10 Finland

Benign neoplasm: Rectosigmoid junction

4.2

16.0

101

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.7

16.0

290

1746

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.5

15.8

681

5004

A04

ICPC

Weakness/tiredness general

1.7

15.7

293

1776

G03HA01

ATC

cyproterone; systemic

5.0

15.7

N02BF02

ATC

pregabalin; oral

2.1

15.7

160

800

207

Kela drug reimbursment

Chronic arrhythmias

1.6

15.5

386

2520

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

2.0

15.5

180

943

R96

ICPC

Asthma

1.8

15.3

218

1221

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.1

15.3

148

726

R02

ICPC

Shortness of breath/dyspnoea

1.7

15.3

293

1790

JGA05

NOMESCO Finland

Endoscopic polypectomy in rectum

5.9

15.2

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

15.2

442

2991

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

15.2

282

1708

JFH00

NOMESCO Finland

Total colectomy and ileorectal anastomosis

17.8

15.1

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.3

15.1

111

487

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.0

15.0

159

806

J01FA10

ATC

azithromycin; systemic

1.4

15.0

1444

12127

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

15.0

428

2887

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

14.8

1120

9055

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

14.8

251

1481

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.9

14.8

177

938

C10AA05

ATC

atorvastatin; oral

1.4

14.7

1216

9965

M48.0

ICD-10 Finland

Spinal stenosis

1.7

14.7

285

1745

K03.64

ICD-10 Finland

Dental calculus supragingival

1.4

14.5

766

5832

XG474

NOMESCO Finland

Exhalation nntrogen oxide

3.5

14.4

137

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.1

14.4

142

702

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

5.2

14.4

R05

ICD-10 Finland

Cough

1.5

14.4

500

3516

R39.1

ICD-10 Finland

Other difficulties with micturition

2.5

14.3

368

D11

ICPC

Diarrhoea

1.8

14.3

242

1429

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.9

14.2

191

1050

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

14.2

1412

11880

UJF92

NOMESCO Finland

Capsular endoscopy

3.9

14.2

106

H02

ICPC

Hearing complaint

1.6

14.2

335

2158

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.9

14.2

177

950

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

14.2

864

6736

I78.1

ICD-10 Finland

Naevus, non-neoplastic

3.1

14.2

194

C10AA01

ATC

simvastatin; oral

1.4

14.1

1098

8900

S29

ICPC

Skin symptom/complaint other

1.5

14.1

464

3223

N06AX16

ATC

venlafaxine; oral

1.7

14.1

278

1710

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.2

14.1

120

560

R05

ICPC

Cough

1.5

14.1

559

4035

SFA20

NOMESCO Finland

Two-surface restoration

1.3

14.0

1534

13083

A01

ICPC

Pain general/multiple sites

1.8

14.0

206

1166

D01

ICPC

Abdominal pain/cramps general

1.7

14.0

242

1437

R50.9

ICD-10 Finland

Fever, unspecified

1.6

13.9

340

2208

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

13.9

1021

8198

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.8

13.9

216

1243

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

13.8

626

4630

J01DA01

ATC

[U] cefalexin

1.3

13.8

1627

14015

L08

ICPC

Shoulder symptom/complaint

1.5

13.8

566

4111

GX1D5

NOMESCO Finland

Flow volume spirometry

20.1

13.8

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.0

13.8

158

825

A46

ICD-10 Finland

Erysipelas

1.6

13.7

381

2551

SFA10

NOMESCO Finland

One-surface restoration

1.3

13.5

1393

11753

L15

ICPC

Knee symptom/complaint

1.4

13.5

610

4507

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

4.5

13.5

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.9

13.4

180

990

A29

ICPC

General symptom/complaint other

1.6

13.4

289

1821

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.0

13.4

201

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

25.8

13.4

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

11.5

13.3

K59.1

ICD-10 Finland

Functional diarrhoea

2.2

13.2

114

535

XF640, ,

NOMESCO Finland

2.7

13.2

269

R60.9

ICD-10 Finland

Oedema, unspecified

2.1

13.2

127

622

R55

ICD-10 Finland

Syncope and collapse

1.7

13.2

248

1506

R01AD09

ATC

mometasone; nasal

1.3

13.2

1080

8801

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

5.8

13.2

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.4

13.2

358

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

13.1

222

1310

JFA85

NOMESCO Finland

Endoscopic mucosal or submucosal resection in colon

12.2

13.1

SPAT1240

SPAT

Therapeutic discussion

1.9

13.0

177

977

R5120

NOMESCO Finland

Preparation of an aid

3.1

13.0

167

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.9

13.0

173

949

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

4.2

13.0

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.9

12.9

175

965

B01AF01

ATC

rivaroxaban; oral

1.6

12.9

317

2061

N05CF01

ATC

zopiclone; oral

1.4

12.9

747

5760

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

12.8

214

1257

M01AB05

ATC

diclofenac; systemic, rectal

1.3

12.8

1864

16463

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.4

12.8

810

6338

G04BE01

ATC

alprostadil; parenteral, urethral

2.8

12.8

234

N06AB04

ATC

citalopram; systemic

1.5

12.6

443

3115

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.6

12.6

293

A03FA02

ATC

cisapride; oral, rectal

1.9

12.6

163

886

WX402

NOMESCO Finland

General anaesthesia

1.4

12.6

618

4631

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

12.6

1809

15935

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.7

12.5

259

EB1VA, ,

NOMESCO Finland

1.5

12.5

450

3183

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

12.4

1665

14514

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.4

12.3

339

SDA03

NOMESCO Finland

Periodontal treatment

1.3

12.3

1032

8420

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

12.3

260

1629

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

12.3

526

3844

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.8

12.2

206

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.8

12.2

178

1006

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.9

12.2

201

E66.8

ICD-10 Finland

Other obesity

2.1

12.2

116

567

XF602

NOMESCO Finland

Bloodpressure monitoring

4.4

12.1

L29

ICPC

Musculoskeletal sympt/complt other

1.8

12.1

195

1134

JF2AD

NOMESCO Finland

Colon CT

6.0

12.1

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

2.8

12.1

207

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

12.1

336

2247

R33

ICD-10 Finland

Retention of urine

1.7

12.1

225

1363

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

12.1

186

1068

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

3.3

12.0

134

SPAT1172

SPAT

Guidance concerning hydration

3.3

12.0

134

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.5

12.0

307

E66.00

ICD-10 Finland

Metabolic syndrome

1.9

12.0

145

772

R52.2

ICD-10 Finland

Other chronic pain

2.5

11.8

297

XCH00

NOMESCO Finland

Eye pressure measurement

2.3

11.7

359

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.8

11.7

162

900

V03AE01

ATC

polystyrene sulfonate; oral

3.6

11.7

107

D12.9

ICD-10 Finland

Benign neoplasm: Anus and anal canal

4.5

11.7

L13

ICPC

Hip symptom/complaint

1.5

11.6

448

3206

JFA45

NOMESCO Finland

Endoscopic contact coagulation in colon

5.5

11.6

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

11.5

476

3452

K92.1

ICD-10 Finland

Melaena

2.0

11.5

127

655

A02BA02

ATC

ranitidine; systemic

1.5

11.5

446

3196

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.8

11.5

176

1009

R74

ICPC

Upper respiratory infection acute

1.4

11.5

684

5287

X58

ICD-10 Finland

Exposure to other specified factors

1.5

11.5

338

2290

N06AX12

ATC

bupropion; oral

2.0

11.5

129

670

L82

ICD-10 Finland

Seborrhoeic keratosis

1.4

11.4

503

3691

D12

ICPC

Constipation

2.3

11.4

351

M79.1

ICD-10 Finland

Myalgia

1.6

11.4

298

1965

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

11.4

452

3253

J01FA09

ATC

clarithromycin; systemic

1.4

11.4

759

5970

M54

ICD-10 Finland

Dorsalgia

1.6

11.4

279

1813

R06.5

ICD-10 Finland

Mouth breathing

1.7

11.4

218

1332

A02BC03

ATC

lansoprazole; oral

1.4

11.3

661

5090

Y06

ICPC

Prostate symptom/complaint

2.2

11.3

455

L14

ICPC

Leg/thigh symptom/complaint

1.8

11.3

173

992

UJG02

NOMESCO Finland

Proctoscopy

2.7

11.3

221

R07.3

ICD-10 Finland

Other chest pain

1.7

11.2

222

1367

DFF15

NOMESCO Finland

Speech audiometry

2.6

11.2

245

R13

ICD-10 Finland

Dysphagia

1.9

11.2

147

804

L16

ICPC

Ankle symptom/complaint

1.6

11.2

245

1549

N06AA09

ATC

amitriptyline; systemic

1.7

11.2

188

1108

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.7

11.2

216

1323

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

11.1

286

1878

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.6

11.1

271

1758

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

11.1

394

2773

L84

ICD-10 Finland

Corns and callosities

2.3

11.1

337

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

5.3

11.1

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.8

11.0

166

948

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

11.0

258

1660

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.3

11.0

834

6686

S06.0

ICD-10 Finland

Concussion

1.7

11.0

217

1337

LCA06

NOMESCO Finland

Biopsy of endometrium

1.6

10.9

230

1439

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.5

10.9

284

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.4

10.9

675

5246

H36.00

ICD-10 Finland

Diabetic background retinopathy

4.1

10.9

J01CA08

ATC

pivmecillinam; oral

1.3

10.8

758

6001

WX320

NOMESCO Finland

Spinalanesthesy

1.4

10.8

624

4793

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.2

10.8

128

103

Kela drug reimbursment

Diabetes, insulin-treated

1.4

10.8

671

5216

Z75.2

ICD-10 Finland

Other waiting period for investigation and treatment

4.3

10.8

ZXA10

NOMESCO Finland

Bilateral

1.5

10.7

415

2970

A11CC03

ATC

alfacalcidol; systemic

2.7

10.7

221

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

10.7

149

830

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.4

10.6

306

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.8

10.6

151

848

H02AB07

ATC

prednisone; oral

1.5

10.6

314

2130

C03DA01

ATC

spironolactone; oral

1.6

10.6

281

1860

A10AB05

ATC

insulin aspart; parenteral

1.8

10.6

152

856

T89

ICPC

Diabetes insulin dependent

2.4

10.5

307

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.8

10.5

153

864

N02AA05

ATC

oxycodone; systemic

1.4

10.5

420

3025

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

10.5

427

3085

LDA20

NOMESCO Finland

Biopsy of vaginal cervix

2.0

10.5

117

606

L12

ICPC

Hand/finger symptom/complaint

1.5

10.4

374

2638

H04AA01

ATC

glucagon; nasal, parenteral

3.4

10.4

106

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

10.4

600

4605

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.8

10.4

163

942

J02AC01

ATC

fluconazole; systemic

1.3

10.4

832

6712

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.6

10.4

247

1594

TFP20

NOMESCO Finland

Cardiodefibrillation

1.7

10.3

181

1079

F34.1

ICD-10 Finland

Dysthymia

2.5

10.3

255

G04BD08

ATC

solifenacin; oral

1.8

10.3

141

781

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

10.3

285

1904

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

10.3

716

5658

A10BJ06

ATC

semaglutide; parenteral

1.8

10.3

139

768

E10

ICD-10 Finland

Type 1 diabetes mellitus

3.4

10.3

107

V03AE02

ATC

sevelamer; oral

8.8

10.3

C07AG02

ATC

carvedilol; oral

1.8

10.2

142

791

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.6

10.2

221

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.2

10.2

395

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

2.9

10.2

154

ZXD05

NOMESCO Finland

Urgent procedure

1.3

10.2

694

5467

G44.2

ICD-10 Finland

Tension-type headache

1.6

10.2

243

1570

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

10.1

580

4445

K78

ICPC

Atrial fibrillation/flutter

1.8

10.1

164

958

K07

ICPC

Swollen ankles/oedema

2.1

10.1

450

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

10.1

450

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.7

10.0

180

1080

L57.0

ICD-10 Finland

Actinic keratosis

1.6

10.0

248

1614

C10AA07

ATC

rosuvastatin; oral

1.3

10.0

930

7648

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.8

10.0

140

781

Z80.8

ICD-10 Finland

Family history of malignant neoplasm of other organs or systems

8.4

10.0

NA3AA, ,

SPAT

2.1

10.0

444

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.5

10.0

259

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

10.0

630

4902

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

10.0

680

5353

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

10.0

134

739

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

9.9

675

5310

H66.9

ICD-10 Finland

Otitis media, unspecified

1.9

9.9

114

597

R06AE07

ATC

cetirizine; oral

1.3

9.9

991

8229

SFA30

NOMESCO Finland

Three-surface restoration

1.3

9.9

1142

9659

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.1

9.9

130

R03BA05

ATC

fluticasone; inhalant

1.5

9.9

380

2717

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

2.5

9.9

237

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.8

9.8

155

897

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.3

9.8

337

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.8

9.8

153

884

M04AA01

ATC

allopurinol; systemic

1.5

9.7

329

2292

A06AC51

ATC

ispaghula, combinations; oral

2.0

9.7

490

R15

ICD-10 Finland

Faecal incontinence

2.7

9.7

186

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

4.1

9.7

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

7.4

9.7

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

3.9

9.7

M01AE02

ATC

naproxen; oral, rectal

1.3

9.7

1437

12532

P03

ICPC

Feeling depressed

1.8

9.7

146

835

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

9.6

172

1031

M05BA04

ATC

alendronic acid; oral

1.8

9.6

147

843

H3600, E103,

ICD-10 Finland

5.3

9.6

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

9.6

530

4034

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

5.0

9.6

EC1VA, ,

NOMESCO Finland

2.0

9.5

108

563

N05AH04

ATC

quetiapine; oral

1.5

9.5

323

2253

R2110

NOMESCO Finland

Giving the first information

1.8

9.5

135

758

R03DC03

ATC

montelukast; oral

1.5

9.5

332

2330

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.3

9.5

291

J45.8

ICD-10 Finland

Mixed asthma

2.5

9.5

218

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.2

9.4

368

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

9.4

130

723

-60

ICPC

Result test/procedure

1.9

9.4

114

608

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.4

9.4

411

3006

A10AB01

ATC

insulin (human); parenteral

2.4

9.4

273

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

9.4

216

1383

Z26.8

ICD-10 Finland

Need for immunization against other specified single infectious diseases

3.6

9.4

A10AE05

ATC

insulin detemir; parenteral

2.0

9.4

102

525

H13

ICPC

Plugged feeling ear

1.4

9.4

435

3217

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

9.4

1096

9273

GD1AA, ,

SPAT

1.4

9.3

364

2607

A10BK01

ATC

dapagliflozin; oral

1.6

9.3

194

1211

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

9.3

597

4650

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

8.0

9.3

K62.7

ICD-10 Finland

Radiation proctitis

4.7

9.3

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.7

9.2

163

975

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.1

9.2

385

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

9.2

1113

9448

TQW20

NOMESCO Finland

Tatoe

3.1

9.2

120

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

7.3

9.2

L29.9

ICD-10 Finland

Pruritus, unspecified

2.5

9.2

233

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

9.2

920

7626

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.7

9.2

169

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

9.2

302

2093

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.2

9.2

353

A10AB04

ATC

insulin lispro; parenteral

2.6

9.1

204

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

2.7

9.1

181

D02AE01

ATC

carbamide; topical

1.8

9.1

136

775

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.5

9.1

228

Z3229

NOMESCO Finland

Other healthcare associate professional

1.7

9.1

154

910

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.2

9.1

322

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.3

9.1

284

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.5

9.1

251

1677

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.4

9.0

241

N29

ICPC

Neurological sympt/complt other

2.8

9.0

154

D07AD01

ATC

clobetasol; topical

1.4

9.0

394

2882

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.1

9.0

382

A10AA01, ,

ATC

2.6

9.0

194

N17

ICPC

Vertigo/dizziness

1.5

9.0

246

1640

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.6

8.9

210

1351

TK820

NOMESCO Finland

Peritoneal dialysis

7.4

8.9

Z09.9

ICD-10 Finland

Follow-up examination after unspecified treatment for other conditions

24.1

8.9

K64.2

ICD-10 Finland

Third degree haemorrhoids

2.7

8.9

172

H25.8

ICD-10 Finland

Other senile cataract

1.6

8.9

212

1369

A97

ICPC

No disease

1.4

8.9

465

3507

M01AH02

ATC

rofecoxib; oral

1.5

8.9

271

1849

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

8.9

534

4118

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

8.9

582

4548

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

4.3

8.9

N06AB06

ATC

sertraline; oral

1.6

8.8

206

1323

R87.6

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal cytological findings

1.7

8.8

164

995

G04CB01

ATC

finasteride; oral

1.5

8.8

308

2160

K62.1

ICD-10 Finland

Rectal polyp

3.2

8.8

103

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

8.7

215

1399

R29

ICPC

Respiratory symptom/complaint other

1.8

8.7

136

786

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

2.3

8.7

277

N05BA04

ATC

oxazepam; oral

1.4

8.7

536

4149

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.4

8.7

364

2643

N05CF02

ATC

zolpidem; oral

1.4

8.7

372

2712

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

4.3

8.7

IHA10

NOMESCO Finland

Structured mapping of problematic alcohol use

4.3

8.7

M01AH05

ATC

etoricoxib; oral

1.3

8.6

1697

15209

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.9

8.6

101

535

B01AA03

ATC

warfarin; systemic

1.4

8.5

429

3212

C50.99

ICD-10 Finland

Breast, unspecified

2.4

8.5

248

ZY010

NOMESCO Finland

Hospital outpatient

2.1

8.5

384

C09CA06

ATC

candesartan; oral

1.3

8.5

606

4791

R21

ICPC

Throat symptom/complaint

1.4

8.5

360

2618

R03BA08

ATC

ciclesonide; inhalant

1.6

8.5

175

1091

Z23.5

ICD-10 Finland

Need for immunization against tetanus alone

3.2

8.5

100

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.2

8.5

100

8263/2-C18.9

ICD-O-3

Adenocarcinoma in situ in tubulovillous adenoma of colon, NOS

27.6

8.5

S97

ICPC

Chronic ulcer skin

1.8

8.5

133

770

H81

ICPC

Excessive ear wax

1.4

8.5

444

3348

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

8.5

128

733

C07AA05

ATC

propranolol; systemic

1.4

8.5

399

2956

A07AA02

ATC

nystatin; oral

1.9

8.5

107

580

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.0

8.4

488

EBA00

NOMESCO Finland

Extraction of tooth

1.3

8.4

863

7162

E000001, ,

ATC

1.4

8.4

408

3039

WX892

NOMESCO Finland

Monitored bed care

1.6

8.4

174

1087

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.9

8.4

101

539

L01

ICPC

Neck symptom/complaint

1.5

8.4

315

2241

XX2XT

NOMESCO Finland

Other injection with other radiological guidance

12.8

8.4

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

8.4

2597

24540

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.2

8.4

327

F29

ICPC

Eye symptom/complaint other

1.5

8.3

228

1519

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

3.3

8.3

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

8.3

559

4379

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.6

8.3

184

ZYC05, ,

SPAT

2.4

8.3

220

G04BD12

ATC

mirabegron; oral

1.5

8.3

251

1709

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

8.3

333

2397

N76.0

ICD-10 Finland

Acute vaginitis

2.1

8.3

381

G04BE08

ATC

tadalafil; oral

10.8

8.3

EB1BA

NOMESCO Finland

Extensive intraoral X-ray examination

10.8

8.3

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.7

8.3

145

866

K22

ICPC

Risk factor cardiovascular disease

1.8

8.3

120

679

ACC51

NOMESCO Finland

Release of median nerve

1.6

8.3

167

1036

B02AA02

ATC

tranexamic acid; systemic

1.4

8.2

314

2239

GX1E5, ,

SPAT

3.5

8.2

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

2.0

8.2

423

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

8.2

132

770

Z40.0

ICD-10 Finland

Prophylactic surgery for risk-factors related to malignant neoplasms

14.5

8.2

A91

ICPC

Abnormal result investigation NOS

1.7

8.2

132

771

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.9

8.1

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

8.1

497

3838

N03AE01

ATC

clonazepam; systemic

1.8

8.1

108

595

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

8.1

553

4341

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.3

8.1

254

SPAT1229

SPAT

Assessment of need for aid

1.7

8.1

135

796

A10AE04

ATC

insulin glargine; parenteral

1.6

8.1

193

1248

TJF80

NOMESCO Finland

Ostomy education

3.2

8.1

AN1

Coronary angiography

1.5

8.1

228

1531

OAB47, ,

SPAT

1.8

8.1

121

692

IHZ05, ,

SPAT

2.2

8.0

287

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

2.9

8.0

125

R03AC03

ATC

terbutaline; inhalant

1.5

8.0

284

1998

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

3.1

8.0

104

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.1

8.0

367

LDA10

NOMESCO Finland

Curettage of cervix uteri

2.0

7.9

408

W19

ICD-10 Finland

Unspecified fall

1.6

7.9

203

1333

A02BC01

ATC

omeprazole; systemic

1.3

7.9

622

4978

A10BK03

ATC

empagliflozin; oral

1.5

7.9

249

1709

C08CA05

ATC

nifedipine; systemic

1.7

7.9

127

740

T78.3

ICD-10 Finland

Angioneurotic oedema

3.2

7.9

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

7.9

141

846

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

7.9

255

1759

U08

ICPC

Urinary retention

2.3

7.9

269

KDV12

NOMESCO Finland

Urethroscopic internal urethrotomy

3.3

7.9

A06AD11

ATC

lactulose; oral

1.4

7.9

301

2145

TK800

NOMESCO Finland

Hemodialysis

2.5

7.9

195

B01AC04

ATC

clopidogrel; oral

1.4

7.9

369

2729

J01AA04

ATC

lymecycline; systemic

1.5

7.9

261

1811

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.0

7.9

382

OAB36, ,

SPAT

2.1

7.9

335

XF600

NOMESCO Finland

Bloodpressure measurement

1.7

7.9

143

863

N92.5

ICD-10 Finland

Other specified irregular menstruation

2.7

7.9

143

Z97.2

ICD-10 Finland

Presence of dental prosthetic device (complete)(partial)

2.2

7.9

283

K59.0

ICD-10 Finland

Constipation

1.8

7.8

109

610

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

4.1

7.8

177

Kela drug reimbursment

Insulin glargine 300 U / ml

2.9

7.8

127

G35

ICD-10 Finland

Multiple sclerosis

3.2

7.8

ZXC20

NOMESCO Finland

Use of chemical agents

2.4

7.7

209

J33.8

ICD-10 Finland

Other polyp of sinus

2.4

7.7

209

P01

ICPC

Feeling anxious/nervous/tense

1.6

7.7

162

1016

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.4

7.7

222

J34.2

ICD-10 Finland

Deviated nasal septum

1.7

7.7

122

710

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

3.2

7.7

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.7

7.7

134

801

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

7.6

135

809

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

2.1

7.6

306

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

7.6

235

1607

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.5

7.6

249

1723

Z30.2

ICD-10 Finland

Sterilization

1.5

7.6

220

1484

SPAT1263

SPAT

Sampling

1.3

7.6

872

7319

N01

ICPC

Headache

1.6

7.6

167

1058

GX2C5

NOMESCO Finland

Short-lasting oximetry

8.0

7.6

M54.2

ICD-10 Finland

Cervicalgia

1.6

7.6

162

1020

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

25.1

7.6

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

7.6

129

766

H93.1

ICD-10 Finland

Tinnitus

1.6

7.6

151

935

R03BA02

ATC

budesonide; inhalant

1.4

7.5

373

2784

R4190

NOMESCO Finland

Nutritional therapy

1.9

7.5

458

P25

ICPC

Phase of life problem adult

2.1

7.5

301

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

6.2

7.5

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

2.8

7.5

124

ZXE00

NOMESCO Finland

One hour or less

1.3

7.5

995

8490

U28

ICPC

Limited function/disability (U)

3.3

7.5

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

7.5

1110

9590

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.9

7.5

459

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.5

7.5

182

D07AC01

ATC

betamethasone; topical

1.3

7.5

880

7407

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

7.5

502

3929

NH1AD

NOMESCO Finland

Ankle and foot CT

2.4

7.5

219

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.6

7.5

181

1175

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

2.0

7.4

425

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.3

7.4

545

4318

H61.2

ICD-10 Finland

Impacted cerumen

1.6

7.4

161

1017

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

7.4

262

1841

R4120, ,

SPAT

3.1

7.4

N39.3

ICD-10 Finland

Stress incontinence

1.7

7.4

120

702

TAB00

NOMESCO Finland

Lumbar puncture

2.0

7.4

398

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.7

7.4

142

DJD20

NOMESCO Finland

Plastic repair of septum of nose

1.9

7.4

461

R07.0

ICD-10 Finland

Pain in throat

1.7

7.4

130

778

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.8

7.4

533

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

2.8

7.4

131

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

7.4

473

3677

R06AX22

ATC

ebastine; oral

1.4

7.4

342

2526

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

2.6

7.4

154

R01AD58

ATC

fluticasone, combinations; nasal

1.3

7.4

516

4063

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.7

7.3

H3603, E113,

ICD-10 Finland

4.0

7.3

R11

ICD-10 Finland

Nausea and vomiting

1.7

7.3

143

880

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.5

7.3

199

1325

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

2.4

7.3

190

WX290

NOMESCO Finland

Other blockage of nerve

1.2

7.3

1102

9534

Z12.6

ICD-10 Finland

Special screening examination for neoplasm of bladder

+∞

7.3

GX1R5

NOMESCO Finland

Peak expiratory flow (PEF) measurement

+∞

7.3

PC6DE, ,

NOMESCO Finland

+∞

7.3

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

10.9

7.3

R12

ICD-10 Finland

Heartburn

1.6

7.3

164

1046

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.6

7.3

157

991

C09AA05

ATC

ramipril; oral

1.3

7.3

622

5031

SPAT1216

SPAT

Assessment of functional ability

1.5

7.3

263

1857

N99.1

ICD-10 Finland

Postprocedural urethral stricture

4.1

7.3

D18

ICPC

Change in faeces/bowel movements

2.2

7.3

247

ZA1.0

ICD-10 Finland

Shoulder region

2.3

7.3

228

M75

ICD-10 Finland

Shoulder lesions

1.8

7.2

105

595

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.3

7.2

241

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

6.2

7.2

PA6AD

NOMESCO Finland

CT of neck arteries

2.0

7.2

381

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

5.8

7.2

K03.00

ICD-10 Finland

Approximal wear

1.6

7.2

164

1049

H29

ICPC

Ear symptom/complaint other

1.5

7.2

250

1752

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.3

7.2

513

4049

U14

ICPC

Kidney symptom/complaint

2.6

7.2

156

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

7.3

7.2

H60.3

ICD-10 Finland

Other infective otitis externa

2.4

7.2

192

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.3

7.2

223

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.3

7.2

223

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

4.5

7.2

NE1DG

NOMESCO Finland

Pelvic, hip and femur very extensive MRI examination with high intensity magnet

4.5

7.2

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

1.9

7.2

438

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.3

7.2

217

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

3.9

7.2

JJC00

NOMESCO Finland

Allogenic transplantation of liver

20.1

7.1

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.7

7.1

135

825

S01

ICPC

Pain/tenderness of skin

1.9

7.1

489

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

3.4

7.1

K02.0

ICD-10 Finland

Caries limited to enamel

1.4

7.1

386

2925

A07EA06

ATC

budesonide; oral, local oral

2.1

7.1

322

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.7

7.1

134

R51.81

ICD-10 Finland

Facial pain NOS

2.5

7.1

175

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.5

7.1

217

1483

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.8

7.1

100

563

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

7.1

550

4393

J20

ICD-10 Finland

Acute bronchitis

1.5

7.0

223

1534

H35.36

ICD-10 Finland

Macular cyst

3.6

7.0

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

2.2

7.0

277

EB4VA, ,

NOMESCO Finland

1.4

7.0

398

3037

CS3P4

NOMESCO Finland

Optic nerve head stereophotography

3.9

7.0

ZX140

NOMESCO Finland

Intra articular

3.9

7.0

SPAT1312

SPAT

General health counselling

1.3

7.0

651

5324

L09

ICPC

Arm symptom/complaint

1.8

7.0

529

FN1AD

NOMESCO Finland

CT of coronary arteries

2.6

6.9

147

WX704

NOMESCO Finland

Intubation

1.6

6.9

172

1123

U07

ICPC

Urine symptom/complaint other

1.6

6.9

172

1123

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

6.9

187

1244

H01

ICPC

Ear pain/earache

1.5

6.9

200

1350

UJH02

NOMESCO Finland

Anoscopy

1.9

6.9

415

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.5

6.9

213

1457

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

2.7

6.9

130

B03XA02

ATC

darbepoetin alfa; parenteral

2.3

6.9

208

D07XC01

ATC

betamethasone; topical

1.4

6.9

280

2020

T90

ICPC

Diabetes non-insulin dependent

1.3

6.9

591

4779

NJ3NA

NOMESCO Finland

Measurement of difference in extremity lengty with X-ray

2.7

6.9

136

S21

ICPC

Skin texture symptom/complaint

1.4

6.9

327

2425

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

3.6

6.9

D06

ICPC

Abdominal pain localized other

1.6

6.9

165

1070

P29

ICPC

Psychological sympt/compl other

1.8

6.8

101

576

M54.8

ICD-10 Finland

Other dorsalgia

1.9

6.8

467

N18.0

ICD-10 Finland

End-stage renal disease

3.4

6.8

A03

ICPC

Fever

1.4

6.8

317

2342

R03BB04

ATC

tiotropium bromide; inhalant

1.5

6.8

223

1545

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.7

6.8

108

629

H3601, E103,

ICD-10 Finland

6.7

6.8

L04AD01

ATC

ciclosporin; systemic

2.6

6.8

149

196

Kela drug reimbursment

Paricalcitol and cinacalcet

6.1

6.8

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

6.8

308

TQW40

NOMESCO Finland

Remowal of suture of skin

1.6

6.7

158

1018

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

5.7

6.7

LFB10

NOMESCO Finland

Excision of lesion of vulva or perineum

4.3

6.7

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

3.6

6.7

ZJX00

NOMESCO Finland

Double balloon technique in gastroenterological endoscopy

16.7

6.7

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.8

6.7

104

601

HAC20

NOMESCO Finland

Total mastectomy

2.0

6.7

377

A10BA02

ATC

metformin; oral

1.3

6.7

696

5760

SPAT1360

SPAT

Extensive global examination

1.7

6.7

116

692

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

6.7

684

5650

XF405

NOMESCO Finland

Symptom ECG

3.9

6.7

R68.2

ICD-10 Finland

Dry mouth, unspecified

3.9

6.7

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

6.7

303

2228

L02AE03

ATC

goserelin; implant

2.6

6.7

144

NH1FA

NOMESCO Finland

Weight-bearing X-ray of ankle

3.4

6.7

E03.89

ICD-10 Finland

Other specified hypothyroidism

1.9

6.7

392

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.7

6.7

107

625

U02

ICPC

Urinary frequency/urgency

1.4

6.7

254

1811

C10AB05

ATC

fenofibrate; oral

2.4

6.7

174

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.7

6.7

125

762

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

1.9

6.7

449

S10

ICPC

Boil/carbuncle

1.7

6.7

124

755

WX140

NOMESCO Finland

Parabulbar anesthesy

1.7

6.6

109

641

J01CF05

ATC

flucloxacillin; systemic

1.6

6.6

154

990

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.6

6.6

157

1014

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

6.6

146

927

HA1RA

NOMESCO Finland

Combined assessment of mammary gland (mammography and ultrasound)

2.2

6.6

244

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

2.9

6.6

105

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.1

6.6

277

CKC15

NOMESCO Finland

Panretinal photocoagulation

4.0

6.6

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

6.6

262

1883

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

5.5

6.6

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

5.5

6.6

XLD00, ,

SPAT

2.7

6.6

122

KMAK, ,

NOMESCO Finland

1.2

6.6

1143

10007

H02BX01

ATC

methylprednisolone, combinations; systemic

1.7

6.6

104

605

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

6.6

495

3933

R06.2

ICD-10 Finland

Wheezing

1.8

6.6

473

XW000

NOMESCO Finland

Bone marrow biopsy

1.9

6.5

452

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.8

6.5

547

RF210, ,

NOMESCO Finland

2.2

6.5

252

A10AA02, ,

ATC

2.1

6.5

292

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.4

6.5

237

1678

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.5

6.5

179

1198

114

Kela drug reimbursment

Glaucoma

1.5

6.5

167

1101

R32

ICD-10 Finland

Unspecified urinary incontinence

2.3

6.5

208

S01ED01

ATC

timolol; ophthalmic

2.0

6.5

334

U06

ICPC

Haematuria

2.1

6.5

300

LFB00

NOMESCO Finland

Biopsy of vulva or perineum

2.4

6.4

177

NOMESCO Finland

Other rehabilitation services

70.0

6.4

XF619

NOMESCO Finland

Other physical examination of heart

70.0

6.4

Z03.0

ICD-10 Finland

Observation for suspected tuberculosis

70.0

6.4

N30.9

ICD-10 Finland

Cystitis, unspecified

1.7

6.4

113

678

NG1EA, ,

SPAT

3.3

6.4

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

6.4

897

7677

WZB00, ,

SPAT

1.5

6.4

168

1112

ULC02

NOMESCO Finland

Hysteroscopy

1.8

6.4

463

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

6.4

138

873

D68.8

ICD-10 Finland

Other specified coagulation defects

3.0

6.4

R08

ICPC

Nose symptom/complaint other

2.0

6.4

336

R5140, ,

SPAT

2.9

6.4

102

P76

ICPC

Depressive disorder

1.8

6.4

537

JN2CM

NOMESCO Finland

Lower part of abdomen extensive MRI examination with Tesla magnet

4.1

6.3

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

1.8

6.3

523

N06AB10

ATC

escitalopram; oral

1.3

6.3

375

2880

NF1AA, ,

SPAT

1.7

6.3

117

712

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.4

6.3

236

1679

R04.0

ICD-10 Finland

Epistaxis

1.5

6.3

167

1108

Z43.3

ICD-10 Finland

Attention to colostomy

11.0

6.3

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

11.0

6.3

SPAT1310

SPAT

Counselling related to known health issue

1.3

6.3

632

5209

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

3.3

6.3

LEB00

NOMESCO Finland

Biopsy of vagina

2.5

6.3

155

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

3.8

6.3

F32

ICD-10 Finland

Depressive episode

1.8

6.2

503

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

2.0

6.2

304

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

26.7

6.2

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.6

6.2

145

934

R35

ICD-10 Finland

Polyuria

1.6

6.2

148

958

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.6

6.2

154

1006

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.9

6.2

367

62660

ICD-8 Finland

Disorders of menstruation, Intermenstrual bleeding

2.8

6.2

109

WX872

NOMESCO Finland

Intensive care

1.7

6.2

109

654

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.0

6.2

312

A12AA04

ATC

calcium carbonate; oral

2.7

6.2

115

R00.2

ICD-10 Finland

Palpitations

1.6

6.2

136

865

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

4.0

6.2

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.6

6.1

154

1009

S01EA05

ATC

brimonidine; ophthalmic

2.3

6.1

194

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

6.1

152

994

R5130, ,

SPAT

7.7

6.1

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

2.3

6.1

188

I48.2

ICD-10 Finland

Chronic atrial fibrillation

1.8

6.1

544

P20

ICPC

Memory disturbance

1.4

6.1

253

1834

M10.9

ICD-10 Finland

Gout, unspecified

1.5

6.1

162

1076

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.3

6.1

182

R01AD08

ATC

fluticasone; nasal

1.3

6.1

614

5061

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.0

6.1

N05AL01

ATC

sulpiride; systemic

3.0

6.1

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.8

6.1

471

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

6.1

374

2889

C05AA08

ATC

fluocortolone; rectal, topical

1.4

6.0

296

2206

H92.0

ICD-10 Finland

Otalgia

1.7

6.0

106

636

J01FA01

ATC

erythromycin; systemic

1.4

6.0

254

1845

N04BC05

ATC

pramipexole; oral

1.6

6.0

143

925

TK810

NOMESCO Finland

Hemofiltration

3.6

6.0

Z80.4

ICD-10 Finland

Family history of malignant neoplasm of genital organs

6.7

6.0

WX202

NOMESCO Finland

Supraclavicular plexus blockade

2.6

6.0

134

A02BA04

ATC

nizatidine; systemic

1.5

6.0

153

1006

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3022145) Colonoscopy Study observation

653

2810

2.67

97.54

1.4

—

(3013512) EKG study

1303

7994

2.07

82.16

4.0

3.2

—

0.81

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1546

10214

2.01

78.12

2.4

1.9

96.01

93.72

pmol/l

1.04

836

5349

(3032080) INR in Blood by Coagulation assay

1670

11381

1.99

76.72

16.4

13.0

1.24

inr

0.01

1391

9167

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

771

4089

2.17

69.28

3.4

2.9

1.47

2.13

e6/l

1.72

427

1697

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1653

11656

1.88

64.11

10.2

6.5

1.21

mmol/l

1.34

1460

9687

(3019225) pH of Specimen

393

1634

2.61

61.01

8.4

3.6

7.38

7.33

7.05

271

1187

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1062

6719

1.88

55.91

3.2

2.8

1230.85

1356.82

ng/l

0.44

907

5738

(3002582) Erythrocytes [#/volume] in Urine

1225

8187

1.81

53.43

4.2

3.0

63.83

110.33

e6/l

1.29

953

5905

(3013826) Glucose [Moles/volume] in Serum or Plasma

1902

14490

1.79

52.74

6.0

4.8

6.73

mmol/l

0.02

1816

13794

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1712

12672

1.77

52.21

7.4

6.7

11.52

12.40

umol/l

2.21

1638

12077

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

941

5889

1.85

50.21

2.7

2.2

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2346

19228

1.86

48.89

10.0

7.6

80.05

80.95

u/l

0.38

2241

18145

(3031040) Bacteria [#/volume] in Urine by Automated count

1978

15420

1.76

48.79

4.8

3.8

1181.91

1669.54

e6/l

0.16

350

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1435

10269

1.73

47.79

2.6

2.2

78.51

76.83

nmol/l

1.40

1262

9308

(3045414) Leukocytes [Presence] in Urine

370

1681

2.36

46.88

3.1

1.8

0.03

0.06

estimate

0.26

350

(3013115) Eosinophils [#/volume] in Blood

1648

12291

1.71

46.87

7.3

5.8

0.20

0.19

e9/l

0.57

1404

10273

(3021960) Folate [Moles/volume] in Serum or Plasma

969

6239

1.80

46.41

1.8

1.6

20.79

19.77

nmol/l

1.08

809

5235

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

741

4391

1.90

46.36

3.3

2.8

0.80

1.15

e6/l

2.21

403

2004

(3018010) Neutrophils/Leukocytes in Blood

1504

10976

1.71

46.04

7.1

5.7

57.79

57.45

0.52

1406

10486

(3044640) Blood type and Crossmatch panel - Blood

1176

8034

1.74

45.70

2.8

2.3

—

(3006315) Basophils [#/volume] in Blood

1601

11919

1.70

45.21

7.0

5.6

0.04

e9/l

0.17

1347

9712

(3001604) Monocytes [#/volume] in Blood

1598

11892

1.70

45.18

7.0

5.6

0.60

e9/l

0.08

1345

9692

(3024561) Albumin [Mass/volume] in Serum or Plasma

1481

10812

1.70

44.88

6.9

4.9

35.71

35.41

g/l

1.22

1401

10096

(3022096) Basophils/Leukocytes in Blood

1501

11003

1.70

44.75

7.5

5.9

0.69

0.68

0.43

1394

10233

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

875

5515

1.81

44.70

2.9

2.0

2.80

2.79

mg/l

0.02

757

4720

(3019069) Monocytes/Leukocytes in Blood

1501

11012

1.69

44.54

7.4

5.9

9.15

9.01

1.13

1394

10275

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

2195

17852

1.76

44.28

5.1

3.7

11.99

12.01

mm/h

0.03

2042

16633

(3006504) Eosinophils/Leukocytes in Blood

1496

10989

1.69

44.00

7.3

5.8

2.95

2.84

1.09

1385

10241

(3018095) Leukocytes [#/volume] in Urine

1311

9311

1.70

43.66

4.8

3.5

66.78

101.89

e6/l

1.41

996

6277

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2822

24929

2.26

43.61

19.6

13.5

26.06

26.95

mg/l

0.62

2404

19984

(3045424) Erythrocytes [Presence] in Urine

223

822

2.84

43.39

3.6

1.9

0.04

0.09

estimate

0.23

271

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

2814

24869

2.23

42.79

19.5

14.0

79.19

80.45

ml/min/173m2

3.14

2637

22779

(40768797) Stomach Pathology biopsy report

543

2968

2.00

42.77

1.4

1.2

—

(3030467) Casts [#/volume] in Urine by Automated count

1064

7175

1.73

42.62

3.8

3.0

0.32

0.56

e6/l

2.98

771

4900

(3037467) Urinalysis macro (dipstick) panel - Urine

2038

16325

1.70

42.48

5.3

3.7

2.51

3.03

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

472

2467

2.07

42.02

6.1

4.4

32.07

31.61

0.35

268

1603

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1431

10482

1.67

41.82

3.6

2.7

155.77

160.73

ug/l

0.15

1323

9738

(3019198) Lymphocytes [#/volume] in Blood

1615

12207

1.66

41.75

7.1

5.6

1.80

1.93

e9/l

3.71

1392

10299

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1458

10758

1.66

41.22

8.4

6.3

1.21

mmol/l

0.53

1322

9976

(4146454) Self-monitoring of blood glucose

6.75

41.21

3.0

1.9

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

373

1806

2.21

40.37

3.3

2.3

0.39

0.53

e6/l

0.52

356

1692

(3033658) Prothrombin time (PT) actual/Normal

1019

6871

1.71

40.35

4.7

3.8

87.45

89.09

1.17

991

6742

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

179

609

3.06

40.19

6.1

3.2

24.18

25.06

mmol/l

4.55

162

551

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2637

22893

1.93

40.14

5.5

4.5

1.88

1.96

mu/l

2.20

2408

20951

(3002030) Lymphocytes/Leukocytes in Blood

1512

11381

1.63

38.60

7.3

5.8

26.91

27.37

0.88

1416

10709

(3013650) Neutrophils [#/volume] in Blood by Automated count

1756

13716

1.63

38.57

9.9

9.4

4.05

4.19

e9/l

1.80

1502

11355

(3022313) Gas panel - Capillary blood

213

825

2.70

37.63

6.3

3.2

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1033

7151

1.66

36.19

2.3

2.0

193.87

211.80

u/l

0.40

977

6726

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

183

669

2.84

36.09

1.8

1.7

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1512

11515

1.60

35.80

3.0

2.6

—

estimate

—

(40768800) Prostate Pathology biopsy report

212

840

2.63

35.78

1.3

1.2

—

(3026782) Osmolality of Urine

755

4828

1.74

35.41

3.4

2.6

559.38

549.32

mosm/kgh2o

0.55

681

4205

(40768804) Tissue Pathology biopsy report

1321

9787

1.60

34.79

2.5

2.1

—

(3026008) Bacteria identified in Urine by Culture

937

6427

1.65

33.50

3.0

2.7

—

(40758558) Short blood count panel - Blood

1039

7321

1.63

33.31

7.0

5.8

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

168

616

2.82

32.93

1.8

1.6

—

(3000850) Epithelial cells [#/volume] in Urine

818

5444

1.68

32.74

3.2

2.4

4.51

5.41

e6/l

0.89

751

4897

(3019550) Sodium [Moles/volume] in Serum or Plasma

2893

26354

2.19

32.59

23.4

15.9

139.77

139.82

mmol/l

0.43

2840

25739

(3023103) Potassium [Moles/volume] in Serum or Plasma

2898

26435

2.20

32.24

23.6

16.1

3.98

mmol/l

0.03

2843

25778

(3022948) Iron [Moles/volume] in Serum or Plasma

615

3801

1.77

32.13

3.4

2.4

12.51

13.39

umol/l

2.35

576

3533

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

689

4467

1.69

30.08

3.9

3.4

884.60

636.72

ng/l

0.26

531

3629

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

545

3323

1.77

29.60

3.4

2.4

22.54

23.60

0.94

509

3067

(3042733) HLA Ab [Presence] in Serum

7.68

29.32

5.9

4.6

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

574

3593

1.73

28.31

3.3

2.3

2.27

g/l

0.02

537

3288

(3007164) IgA [Mass/volume] in Serum or Plasma

628

4034

1.70

28.16

1.5

2.60

2.58

g/l

0.05

381

2576

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

454

2667

1.82

27.81

4.1

4.5

246.35

250.08

u/l

0.14

428

2531

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2045

17214

1.54

27.63

4.0

2.9

57.86

50.01

u/l

3.59

1935

16145

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2713

24450

1.79

27.58

7.5

5.7

39.80

39.11

mmol/mol

4.15

2535

22787

(3003458) Phosphate [Moles/volume] in Serum or Plasma

501

3058

1.76

26.90

9.3

5.2

1.05

1.02

mmol/l

0.98

469

2856

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2937

27216

2.17

26.70

14.5

10.7

27.14

27.33

u/l

0.25

2856

26373

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2957

27474

2.24

26.69

25.9

17.9

81.78

78.52

umol/l

4.52

2918

27144

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

573

3646

1.70

26.45

2.0

1.8

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

278

1409

2.07

26.36

5.6

3.2

5.05

5.15

kpa

1.68

262

1347

(3024932) HLA-DR beta [Type]

7.48

25.88

1.0

1.1

—

(3023368) Bacteria identified in Blood by Culture

957

6930

1.55

25.87

4.4

—

(3024471) HLA-A [Type]

7.25

25.86

1.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2687

24261

1.73

25.67

4.9

4.1

1.33

1.31

mmol/l

0.74

2462

22371

(3027945) Reticulocytes/Erythrocytes in Blood

442

2651

1.78

25.10

2.8

2.5

1.77

1.75

0.17

376

2365

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2839

26105

1.88

24.75

6.5

5.6

2.66

2.75

mmol/l

7.03

2647

24314

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

984

7233

1.52

24.56

3.3

2.5

55.07

84.59

u/l

1.30

907

6693

(3002032) Base excess in Venous blood by calculation

390

2279

1.81

24.12

4.3

3.4

1.71

1.68

mmol/l

0.05

346

1992

(3049717) Cytology report of Urine Cyto stain

207

968

2.22

24.11

2.5

2.8

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

281

1483

1.98

23.76

6.1

3.6

106.53

91.01

ng/l

1.28

250

1279

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

303

1651

1.92

23.32

2.4

2.1

6.53

9.65

ug/l

2.55

258

1474

(3019309) Folate [Moles/volume] in Red Blood Cells

545

3537

1.65

23.04

1.7

986.27

1206.98

nmol/l

7.10

383

2672

(3026493) Urate [Moles/volume] in Serum or Plasma

954

7047

1.51

22.94

3.7

2.5

352.20

349.58

umol/l

0.35

845

6227

(3014051) Protein [Presence] in Urine by Test strip

923

6774

1.51

22.88

2.8

2.5

0.11

0.02

0.37

149

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2732

24955

1.71

22.80

6.1

4.7

6.07

5.95

mmol/l

4.95

2520

22923

(3021447) Carbon dioxide [Partial pressure] in Venous blood

393

2339

1.78

22.79

4.3

3.4

5.79

kpa

0.01

378

2281

(3000991) Gas panel - Venous blood

379

2233

1.79

22.74

9.0

9.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

440

2715

1.72

22.46

1.9

1.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

709

4934

1.56

22.35

1.8

1.6

1.68

1.34

mg/l

0.81

547

3885

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

235

1189

2.06

22.33

5.3

3.1

0.88

2.15

mmol/l

7.33

174

880

(3010813) Leukocytes [#/volume] in Blood

2981

28015

2.19

22.31

29.6

20.4

6.68

e9/l

0.00

2918

27111

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2792

25687

1.76

22.31

5.7

4.9

4.58

4.69

mmol/l

7.06

2591

24065

(3009343) pH of Capillary blood

263

1386

1.98

22.31

5.8

3.2

7.41

7.42

0.83

224

1145

(3000963) Hemoglobin [Mass/volume] in Blood

2981

28018

2.19

22.26

29.8

20.5

135.83

137.11

g/l

4.73

2947

27654

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1181

9147

1.47

22.25

3.8

3.3

34.08

61.64

ng/l

2.17

857

6416

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2780

25552

1.75

22.20

5.8

4.8

1.43

1.45

mmol/l

2.03

2576

23765

(3014111) Lactate [Moles/volume] in Serum or Plasma

381

2266

1.78

22.12

8.0

8.7

1.33

1.34

mmol/l

0.02

365

2226

(3007461) Platelets [#/volume] in Blood

2979

28000

2.17

22.11

29.6

20.4

244.93

247.38

e9/l

1.35

2928

27212

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1105

8460

1.47

22.04

3.8

2.9

34.01

36.51

u/l

0.55

1030

7937

(3035941) MCH [Entitic mass]

2979

28009

2.16

21.94

29.5

20.3

30.47

0.01

2947

27630

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

2979

28010

2.16

21.92

30.2

20.9

40.55

41.12

1.67

2945

27620

(3024731) MCV [Entitic mean volume] in Red Blood Cells

2979

28012

2.16

21.88

29.5

20.3

91.49

91.38

0.75

2947

27635

(3026361) Erythrocytes [#/volume] in Blood

2979

28015

2.16

21.83

29.6

20.3

4.50

4.53

e12/l

2.85

2923

27130

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

447

2791

1.70

21.81

3.4

2.5

7.61

10.29

umol/l

2.71

404

2449

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

204

993

2.13

21.47

1.6

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

241

1258

1.99

20.99

1.7

1.6

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

186

884

2.17

20.81

2.8

2.2

4.12

4.20

g/l

0.55

169

821

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

186

887

2.17

20.63

2.8

2.2

7.26

7.32

g/l

0.16

168

821

(3037522) Nuclear Ab [Titer] in Serum

471

3023

1.66

20.62

1.4

1.3

678.53

436.35

titre

1.57

109

591

(3009508) Creatinine [Moles/volume] in Urine

1140

8864

1.45

20.62

4.1

3.1

7.79

8.17

mmol/l

2.01

937

7419

(3012544) pH of Venous blood

390

2386

1.72

20.43

4.3

3.5

7.38

0.52

232

1165

(3020682) Albumin/Creatinine [Ratio] in Urine

1128

8769

1.45

20.35

4.9

3.9

8.45

7.70

mg/mmol

0.20

699

5395

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2120

18472

1.45

20.33

4.3

3.8

14.68

14.69

pmol/l

0.10

1930

16838

(3042936) Bacteria identified in Isolate by Culture

514

3386

1.62

20.26

2.4

1.9

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

184

883

2.15

20.08

2.8

2.2

3.44

3.89

g/l

5.00

166

819

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

182

872

2.15

19.95

1.9

39.98

40.09

u/l

0.02

154

778

(3023520) Reticulocytes [#/volume] in Blood

332

1955

1.78

19.86

3.2

2.7

69.55

68.81

e9/l

0.15

261

1330

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

419

2633

1.68

19.85

4.2

4.9

14.46

20.16

ug/l

0.28

354

2141

(3000034) Microalbumin [Mass/volume] in Urine

166

3.73

19.58

3.2

2.8

48.70

19.21

mg/l

0.51

124

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

177

845

2.16

19.58

2.8

2.2

2.88

2.98

g/l

0.59

160

780

(4024509) Urine culture

150

669

2.30

19.57

1.8

1.6

—

(40761536) Microorganisms panel - Urine sediment

114

2596

0.42

19.35

3.5

3.4

—

(3020779) Urea [Moles/volume] in Serum or Plasma

350

2110

1.74

19.28

12.0

6.3

11.77

10.05

mmol/l

1.89

338

2039

(3024354) Oxygen [Partial pressure] in Venous blood

327

1935

1.77

19.22

3.7

2.8

4.90

4.53

kpa

1.86

311

1879

(3015377) Calcium [Moles/volume] in Serum or Plasma

1083

8425

1.43

19.18

3.8

4.0

2.35

mmol/l

0.32

961

7747

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1427

11668

1.41

19.03

6.8

5.2

3.29

3.10

ug/l

0.30

1262

10580

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

195

981

2.05

18.80

1.8

1.6

1.45

1.60

g/l

1.22

166

837

(3000330) Specific gravity of Urine by Test strip

200

1017

2.03

18.73

3.5

2.7

1.02

ratio

0.47

185

894

(3005719) IgG [Mass/volume] in Serum or Plasma

283

1626

1.81

18.35

2.9

2.6

10.90

10.94

g/l

0.04

268

1498

(3022689) Creatine [Moles/volume] in Urine

4.81

17.99

1.3

1.4

6.94

8.17

mmol/l

1.07

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

6.50

17.92

2.5

2.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

161

768

2.16

17.85

1.5

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

340

2.76

17.85

1.3

1.2

237.55

253.56

u/ml

0.28

227

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

5.35

17.77

1.1

—

(3017732) Neutrophils [#/volume] in Blood

401

2564

1.65

17.66

3.7

3.1

3.99

4.42

e9/l

1.59

296

2250

(3012516) Albumin [Mass/volume] in Urine

1094

8630

1.41

17.53

4.2

3.2

44.42

48.02

mg/l

0.21

684

5468

(3048689) Calprotectin [Mass/mass] in Stool

376

2379

1.66

17.24

2.2

2.3

161.82

160.30

ug/g

0.02

296

1930

(3044927) Protein electrophoresis panel - Urine

154

3.62

16.98

1.2

1.1

—

(3036489) Thrombin time

172

858

2.06

16.98

2.0

1.9

22.33

20.99

0.50

156

766

(3004616) Nuclear Ab [Presence] in Serum

203

3.25

16.95

1.3

1.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

389

2494

1.64

16.92

1.8

1.6

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

355

2229

1.67

16.75

2.0

1.5

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

533

3693

1.53

16.61

2.2

2.0

29.30

30.10

2.58

518

3599

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

256

1470

1.81

16.60

1.7

1.5

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

163

804

2.08

16.58

2.8

3.1

0.34

iu/ml

0.02

400

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

627

4498

1.49

16.55

1.3

1.2

0.80

2.04

u/ml

5.75

159

1314

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

105

431

2.49

16.52

1.5

1.2

4.79

2.07

u/ml

—

(3037121) Protein [Mass/volume] in Urine

131

599

2.24

16.15

8.0

3.6

361.61

284.56

mg/l

0.69

336

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

30.19

16.10

8.3

3.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

100

408

2.50

15.95

1.4

1.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

121

541

2.29

15.74

1.4

1.2

1.58

2.60

u/ml

1.10

(3012095) Magnesium [Moles/volume] in Serum or Plasma

586

4188

1.49

15.67

3.9

3.4

0.81

0.82

mmol/l

0.89

551

3950

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

161

810

2.04

15.54

2.9

2.4

0.83

0.89

g/l

0.06

142

681

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

418

2784

1.58

15.46

1.9

1.7

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

359

2309

1.63

15.36

3.1

2.0

0.21

g/l

0.26

334

2139

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

265

1573

1.75

15.34

9.5

11.0

24.26

24.19

mmol/l

0.13

256

1549

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

374

2.53

15.30

1.8

1.3

183.79

145.08

au/ml

3.40

133

(3014271) Vancomycin [Susceptibility]

5.64

15.07

2.5

3.0

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

246

1437

1.77

15.05

2.5

2.3

34.55

23.19

au/ml

0.70

175

(3017354) Segmented neutrophils/Leukocytes in Blood

168

3.31

14.90

3.5

3.6

57.72

58.27

0.06

139

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

119

541

2.25

14.90

1.5

1.2

10.58

5.98

u/ml

0.25

(3004119) Hemoglobin [Mass/volume] in Venous blood

252

1493

1.75

14.68

3.3

2.9

131.61

130.95

g/l

0.15

244

1449

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

282

1725

1.70

14.64

1.5

1.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

443

3030

1.54

14.51

2.1

1.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

176

3.22

14.50

1.4

1.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

226

1305

1.79

14.38

1.3

62.69

48.95

au/ml

0.30

102

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

123

577

2.18

14.27

1.4

1.2

1.92

26.26

u/ml

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

569

4117

1.47

14.16

1.3

32.74

37.52

iu/ml

0.31

172

1294

(3027801) Oxygen [Partial pressure] in Arterial blood

426

2905

1.54

14.13

7.8

8.3

12.57

12.34

kpa

0.41

412

2814

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

426

2906

1.54

14.11

7.9

8.3

5.05

5.10

kpa

0.47

412

2816

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

174

3.20

14.10

1.4

1.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

310

1963

1.64

14.08

3.0

2.6

65.84

66.30

g/l

0.46

281

1819

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

180

3.15

13.99

1.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

133

649

2.10

13.96

2.5

2.4

195.98

201.98

0.34

125

623

(3023420) DNA double strand Ab [Units/volume] in Serum

155

802

1.98

13.86

1.6

4.80

6.74

iu/ml

0.74

157

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

142

713

2.04

13.80

2.0

2.2

278.88

620.20

ug/l

1.73

135

671

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

4.88

13.78

5.4

1.6

332.57

383.20

u/ml

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

177

3.14

13.72

2.3

4.2

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

167

3.21

13.68

1.3

1.1

45.60

36.53

u/ml

—

(3004588) Protein electrophoresis panel - Serum or Plasma

257

1561

1.70

13.68

2.7

2.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

223

1304

1.76

13.59

2.1

2.0

1.52

1.35

g/l

0.34

206

1203

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

529

3811

1.47

13.40

1.3

1.2

8.04

13.50

u/ml

1.31

200

1510

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

350

2311

1.58

13.36

5.2

5.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

5.59

13.35

1.0

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

380

2568

1.55

13.09

2.2

2.1

12.98

13.64

nmol/l

0.81

329

2358

(3019977) pH of Arterial blood

420

2903

1.52

13.03

8.0

8.3

7.41

7.42

0.06

191

1384

(3004809) Band form neutrophils/Leukocytes in Blood

312

2.54

13.02

3.4

0.94

1.47

1.14

273

(3021601) Nitrite [Presence] in Urine by Test strip

1508

12931

1.32

12.82

3.8

3.2

0.00

estimate

1.34

252

2790

(3002256) Pathology report gross observation

497

3568

1.47

12.78

1.5

1.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

149

783

1.95

12.76

3.1

2.2

10.28

g/l

0.00

130

713

(3000570) Elastase.pancreatic [Mass/mass] in Stool

120

585

2.09

12.65

1.4

300.17

261.28

ug/g

1.01

348

(3021589) Normoblasts [#/volume] in Blood

1363

11541

1.32

12.61

11.0

11.3

0.00

e9/l

2.08

1098

9006

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

4.51

12.59

1.2

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

4.51

12.59

1.2

2.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

4.51

12.59

1.2

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

4.51

12.59

1.2

2.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

910

7267

1.35

12.58

3.8

3.1

0.94

0.79

ug/l

3.82

653

4673

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

191

1093

1.80

12.53

4.6

3.5

52.71

46.68

2.30

184

1072

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

171

3.08

12.53

1.5

1.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

174

968

1.84

12.52

3.9

2.9

25.27

25.23

mmol/l

0.05

166

936

(3005988) Vibrio sp identified in Specimen by Organism specific culture

172

3.06

12.41

1.5

1.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

415

2890

1.50

12.40

2.0

1.7

1.47

1.46

0.09

360

2494

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

187

1069

1.80

12.32

2.4

2.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

169

3.05

12.14

1.5

1.3

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

132

682

1.98

11.89

2.4

2.5

3.94

3.73

g/l

0.75

126

656

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

137

718

1.95

11.84

2.3

2.0

92.05

91.11

0.17

130

689

(40768446) Kidney Pathology biopsy report

3.96

11.73

2.2

1.6

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

162

3.06

11.72

1.1

1.2

—

(3003396) Base excess in Arterial blood by calculation

413

2906

1.48

11.70

8.0

8.3

0.54

0.69

mmol/l

0.35

348

2443

(3009261) Glucose [Presence] in Urine by Test strip

1526

13221

1.30

11.55

3.9

3.2

0.01

0.02

estimate

0.42

224

2647

(36660697) Celiac disease serology panel - Serum

233

1444

1.66

11.50

1.2

1.1

—

(3035350) Ketones [Presence] in Urine by Test strip

1511

13082

1.30

11.46

3.8

3.2

6.19

3.15

estimate

0.20

257

2826

(3048929) Epstein Barr virus Ab [Presence] in Serum

107

521

2.09

11.35

1.3

1.2

—

(3022621) pH of Urine by Test strip

266

1718

1.60

11.12

2.5

2.3

5.99

6.06

0.61

178

1152

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

207

2.74

10.99

1.8

19.06

26.02

mg/l

0.73

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

169

2.93

10.92

2.3

2.5

11.10

35.25

iu/ml

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

133

711

1.91

10.86

3.2

2.2

0.22

0.01

g/l

0.50

122

627

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

104

511

2.07

10.79

1.3

1.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

380

2671

1.48

10.79

1.9

1.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1615

14172

1.29

10.76

2.7

2.5

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

628

4834

1.37

10.73

3.2

3.5

2.45

mmol/l

1.13

563

4331

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1130

9500

1.30

10.42

4.8

4.3

20.75

21.88

2.10

635

4727

(3005322) IgE [Units/volume] in Serum or Plasma

200

1223

1.68

10.40

1.4

1.3

188.45

268.37

u/ml

0.74

187

1116

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

259

1697

1.57

10.19

2.8

2.6

220.84

190.22

ng/l

0.47

237

1556

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

133

728

1.86

10.12

1.3

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

161

2.88

10.01

4.1

2.2

—

(3016502) Oxygen saturation in Arterial blood

367

2602

1.46

9.95

8.5

8.8

95.56

95.47

0.10

360

2529

(3007566) Smooth muscle Ab [Titer] in Serum

122

654

1.90

9.91

1.2

52.86

239.22

titre

—

(3021440) Promyelocytes/Leukocytes in Blood

301

2053

1.52

9.88

4.7

3.9

0.05

0.14

2.39

547

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

474

2.06

9.86

9.5

3.6

579.00

4550.31

iu/ml

0.44

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

375

2.19

9.82

4.6

2.2

41637.60

2883.15

u/ml

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

158

2.87

9.74

1.4

1.8

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

142

2.98

9.72

1.5

1.8

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

132

731

1.84

9.70

1.6

1.7

19.06

20.28

u/ml

0.07

227

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

107

554

1.96

9.64

1.3

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

334

2340

1.48

9.61

3.5

2.3

36.56

43.39

u/l

0.66

284

1991

(1761482) Bacteria [#/volume] in Urine by Culture

105

546

1.95

9.35

3.8

3.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

344

2.21

9.32

1.4

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

4.90

9.30

2.0

1.7

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

117

635

1.88

9.17

3.4

2.2

0.00

g/l

-0.00

110

598

(3000475) Leukocytes [#/volume] in Synovial fluid

105

554

1.93

8.98

1.6

1.5

7517.44

15568.73

e6/l

1.92

366

(3021879) Hepatitis B virus core Ab [Presence] in Serum

234

1547

1.55

8.86

1.3

—

(3017181) Myelocytes/Leukocytes in Blood

305

2139

1.47

8.73

4.7

3.9

0.86

1.02

0.52

633

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

106

567

1.90

8.71

2.1

2.0

13.14

11.24

mg/l

1.53

536

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

451

2.00

8.56

3.8

1.4

0.90

0.83

nmol/l

0.47

402

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.81

8.51

4.6

2.3

0.62

0.61

mmol/l

0.15

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

126

2.96

8.50

1.2

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

126

2.96

8.50

1.2

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

126

2.96

8.50

1.2

1.6

—

(3002179) Metamyelocytes/Leukocytes in Blood

290

2026

1.48

8.46

4.4

3.8

0.70

0.78

0.19

101

566

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

2341

21808

1.29

8.44

23.1

17.0

331.83

332.76

g/l

5.55

2329

21670

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

106

3.14

8.37

1.4

1.9

302.61

318.72

mu/l

0.11

(4195642) Thrombophilia screening test

277

2.26

8.24

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

3.83

8.23

1.5

1.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

271

1878

1.48

8.23

2.7

2.6

386.73

385.51

nmol/l

0.03

252

1762

(40761535) Cells panel - Urine sediment

211

1394

1.55

8.03

4.2

2.7

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

455

1.96

8.02

1.6

1.5

—

(3015736) pH of Urine

1186

10270

1.25

7.98

3.4

2.8

6.12

6.10

0.16

626

5574

(4035726) Immunohistochemistry procedure

330

2391

1.42

7.94

1.4

—

(3018418) pH of Serum or Plasma

903

7584

1.27

7.90

4.4

3.9

7.40

0.14

619

5038

(3019832) Treponema pallidum Ab [Presence] in Serum

178

1135

1.60

7.90

2.2

1.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

309

2.16

7.85

1.2

3.79

3.68

u/ml

0.04

148

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

119

687

1.76

7.69

3.4

2.2

0.01

0.00

g/l

0.50

110

600

(40768443) Skin Pathology biopsy report

171

1093

1.60

7.52

1.3

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

302

2.14

7.48

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

191

1261

1.55

7.31

2.0

1.6

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

131

791

1.68

7.23

4.0

3.3

39.92

55.71

mg/l

0.46

119

610

(3025159) Blasts/Leukocytes in Blood

283

2035

1.43

7.10

5.1

4.0

0.01

0.28

1.02

512

(3024928) Oxygen saturation in Venous blood

110

639

1.75

6.99

3.0

2.9

63.16

62.84

0.06

104

621

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

382

2904

1.36

6.89

1.7

1.5

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

367

1.98

6.88

1.1

15.20

1835.05

iu/ml

0.51

(3034860) Kappa light chains.free [Mass/volume] in Serum

129

791

1.66

6.74

4.1

3.3

53.88

58.28

mg/l

0.15

117

608

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.90

6.70

1.2

2.2

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

3.90

6.70

3.0

1.6

49.89

57.67

ug/l

0.26

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.90

6.70

1.2

2.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

171

1128

1.55

6.60

1.9

1.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.82

6.53

1.2

2.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

189

2.35

6.48

1.2

1.1

—

(3044889) 12 lead EKG panel

2033

18864

1.22

6.40

4.0

3.7

—

0.41

—

(3032057) Clostridioides difficile [Presence] in Stool

6.55

6.33

1.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

107

638

1.70

6.23

1.1

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

238

2.16

6.19

4.2

3.3

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

265

2.09

6.16

1.6

1.5

57.45

57.58

0.01

158

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

520

1.77

6.16

1.1

6.03

3.14

—

(3019150) Specific gravity of Urine by Refractometry

640

5296

1.26

6.14

3.4

3.3

1.02

kg/l

0.64

456

3151

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

116

711

1.66

6.10

4.2

3.1

2.14

2.67

ratio

0.32

310

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

101

598

1.71

6.04

1.3

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

215

1515

1.45

6.04

9.1

10.2

16.08

16.09

0.01

210

1472

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

111

2.72

6.01

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

458

1.81

6.00

1.4

1.2

37.06

51.92

u/ml

0.35

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

324

1.96

5.93

1.3

1.2

4.82

3.73

u/ml

0.12

106

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

298

2.00

5.84

1.1

122.21

116.97

0.58

262

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

143

933

1.56

5.83

4.0

4.4

1.62

1.65

0.11

138

885

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.84

5.67

1.4

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.84

5.67

1.4

1.3

—

(21494434) Karyotype in Bone marrow

157

2.37

5.64

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

104

2.71

5.59

1.9

1.6

1.00

1.31

nmol/l

1.36

(3000494) Fungus identified in Specimen by Culture

366

2859

1.32

5.48

1.6

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

3.15

5.46

1.4

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

3.15

5.46

1.4

1.3

—

(3048879) Bone marrow aspiration report

5.19

5.38

1.1

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

519

1.72

5.38

2.6

1.5

—

(3020876) Protein [Mass/time] in 24 hour Urine

280

1.98

5.36

2.7

1.34

1.51

g/24h

0.20

183

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

3.19

5.31

1.0

1.1

0.70

2.75

u/ml

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

476

1.74

5.31

1.2

1.3

514.99

578.49

mg/l

0.74

456

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

309

1.93

5.30

2.6

1.7

340.15

1587.11

u/l

1.70

123

(3010144) Erythrocytes [#/volume] in Synovial fluid

194

2.18

5.28

1.4

1.2

17686.28

112713.68

e6/l

1.11

135

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

492

1.73

5.27

1.7

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

137

907

1.53

5.26

2.1

1.6

0.32

0.35

mg/l

0.31

463

(3027315) Oxygen [Partial pressure] in Blood

712

0.44

5.23

3.6

4.2

8.46

8.50

kpa

0.05

700

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

157

2.31

5.18

1.1

1.0

—

(3012501) Base excess in Blood by calculation

709

0.45

5.17

3.6

4.2

2.11

2.62

mmol/l

0.76

485

(3013290) Carbon dioxide [Partial pressure] in Blood

709

0.45

5.17

3.6

4.2

4.99

kpa

0.02

697

(3028433) Virus identified in Specimen by Culture

3.48

5.17

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

3.23

5.17

1.2

1.8

42.28

41.34

g/l

0.30

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

104

649

1.62

5.15

1.7

1.4

1.20

1.22

g/l

0.16

104

618

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

124

809

1.55

5.10

2.5

2.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

364

1.83

5.08

1.8

1.9

4.75

5.28

mmol/24h

0.69

333

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

293

1.93

5.06

1.2

7.94

7.57

mmol/l

0.28

257

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

10.02

5.02

2.9

2.0

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

180

1276

1.44

4.95

3.0

3.8

4.39

4.46

pmol/l

0.49

164

1154

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

103

651

1.60

4.86

1.5

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

444

1.73

4.84

1.5

1.3

11.94

10.06

u/l

0.54

357

(3028707) Methadone [Presence] in Urine by Screen method

125

2.41

4.80

2.6

1.7

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

196

1423

1.40

4.73

1.3

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

526

1.65

4.64

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

526

1.65

4.64

1.1

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

2284

21684

1.19

4.63

23.5

17.3

13.67

13.62

1.01

2270

21275

(3000093) Morphology [Interpretation] in Blood Narrative

205

2.06

4.63

1.4

1.1

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

140

2.30

4.61

4.3

3.9

163.81

285.31

nmol/l

0.35

140

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

8.20

4.56

2.9

1.8

—

(3017704) Immunofixation for Urine

2.56

4.54

1.2

1.7

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

167

2.17

4.52

1.1

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

530

1.64

4.52

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

141

972

1.47

4.51

3.9

4.0

42.69

1720.92

u/ml

1.01

121

844

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

168

2.16

4.46

1.1

282.42

292.32

mg/l

0.26

151

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

3.42

4.46

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

5.81

4.44

1.1

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

5.81

4.44

1.1

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

4.07

4.40

1.1

740.00

1142.86

titre

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

465

1.67

4.38

1.1

0.83

7.38

eliau/ml

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

121

817

1.50

4.30

1.4

1.2

2.71

1.31

u/ml

0.36

(3003181) Sodium [Moles/volume] in Urine

392

1.72

4.29

1.5

1.4

66.69

61.46

mmol/l

0.39

301

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

126

2.31

4.26

1.6

1.5

13.75

29.25

u/ml

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

634

1.56

4.24

1.5

0.05

8.95

iu/ml

0.51

125

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

434

1.67

4.15

1.3

1.4

46.51

28.67

e6/l

0.24

303

(3003694) ABO and Rh group [Type] in Blood

867

7661

1.18

4.12

1.4

—

(3033099) Centromere Ab [Titer] in Serum

4.21

4.01

1.2

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

355

1.73

4.00

3.6

2.5

6.97

248.98

u/ml

1.21

349

(3037756) Immunofixation for Serum or Plasma

478

1.63

3.98

1.7

1.6

—

(3035637) Corticotropin [Mass/volume] in Plasma

268

1.84

3.95

1.7

1.5

40.19

31.45

ng/l

0.27

268

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

254

3227

0.77

3.93

3.2

3.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

3.14

3.92

1.5

1.2

39.41

37.91

g/l

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

144

2.16

3.92

1.1

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

138

2.19

3.89

2.4

2.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

321

1.76

3.88

1.1

1.48

1.52

g/l

0.35

293

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

146

2.13

3.80

1.1

1.0

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

2.43

3.80

2.8

33.83

37.09

0.33

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

166

2226

0.73

3.76

3.9

1.22

mmol/l

0.13

145

1867

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

439

1.63

3.74

1.4

996.96

1461.18

e6/l

0.21

328

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

117

810

1.46

3.72

2.6

1.66

1.52

mg/l

0.89

109

730

(1001926) Buprenorphine [Presence] in Urine by Screen method

303

1.76

3.72

2.3

1.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

319

1.74

3.68

1.1

13.00

12.41

au/ml

0.02

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

142

2.12

3.64

1.1

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

142

2.12

3.64

1.1

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

137

2.13

3.55

1.1

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

2.45

3.54

1.2

1.1

146.50

134.51

nmol/l

0.58

(3020191) Ethanol [Moles/volume] in Serum or Plasma

171

2.00

3.53

1.2

1.4

0.88

1.31

promille

0.88

126

(4094501) Cardiovascular stress test using bicycle ergometer

115

803

1.45

3.52

1.2

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

647

1.50

3.51

1.8

1.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

118

2.21

3.50

1.2

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

116

813

1.44

3.48

1.6

1.8

46.93

42.97

nmol/l

0.78

107

796

(3035933) Granulocytes/Leukocytes in Blood

675

0.54

3.47

3.0

3.1

57.49

57.66

0.03

675

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

152

2.05

3.45

1.1

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

106

2.27

3.45

1.0

1.1

16.22

7.93

nmol/l

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

134

966

1.40

3.45

1.2

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

481

1.57

3.43

1.1

1.2

—

(4015189) Microbial culture of sputum

2.99

3.41

1.9

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.40

3.39

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

3.76

3.38

1.7

1.1

196.07

78.76

mu/l

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

5.01

3.37

1.1

1.7

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.10

3.37

1.2

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

218

1.85

3.31

1.2

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

3.43

3.31

1.2

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

114

808

1.43

3.25

1.6

1.7

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

302

1.70

3.21

1.3

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

206

1.85

3.21

1.4

1.5

—

(44806420) Estimation of glomerular filtration rate

421

0.45

3.21

1.9

2.5

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

143

2.04

3.20

1.1

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

466

1.56

3.19

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

466

1.56

3.19

1.5

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

429

1.57

3.12

1.3

—

(3021788) Differential panel - Synovial fluid

477

1.54

3.11

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

299

1.68

3.06

1.3

1.4

152520.56

55904.75

e6/l

0.34

155

(3018333) Ribosomal P Ab [Presence] in Serum

139

2.02

3.05

1.1

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.90

3.02

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

3.34

3.01

1.3

1.1

414.57

412.38

pmol/l

—

(3011288) Drugs identified in Urine by Screen method Nominal

255

1.74

3.01

4.3

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

653

1.45

3.00

2.8

1.6

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.28

2.93

1.5

1.9

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

2.33

2.91

1.3

1.2

0.61

0.53

ratio

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

358

1.60

2.90

3.5

3.0

0.71

0.83

nmol/l

1.44

287

(3024263) Appearance of Synovial fluid

115

2.10

2.88

2.3

1.5

—

(1616796) Gas panel - Central venous blood

746

0.61

2.84

3.7

3.9

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

578

1.47

2.84

2.1

4.2

34.58

810.06

u/ml

1.73

529

(3023410) Appearance of Cerebral spinal fluid

208

1.79

2.82

1.4

1.5

—

(3023183) Ammonium ion [Moles/volume] in Plasma

546

1.48

2.82

4.0

2.4

31.97

36.62

umol/l

1.51

491

(3023199) Leukocytes [#/volume] in Pleural fluid

330

1.62

2.80

1.3

1.4

1479.62

4862.13

e6/l

0.60

210

(3000060) B lymphocytes [#/volume] in Blood

3.08

2.77

3.2

2.0

0.07

1.26

e9/l

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

2.32

2.74

1.1

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

374

1.56

2.67

1.6

1.7

—

(44806071) Cardiolipin IgM antibody measurement

3.76

2.67

1.1

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.66

2.62

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.93

2.61

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

2.55

2.61

1.1

1.3

0.32

0.31

g/l

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.55

2.61

1.4

2.6

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.06

2.56

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

323

1.59

2.55

1.5

1.2

305.42

281.49

pmol/l

0.21

279

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

5.46

2.54

1.3

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

232

1897

1.24

2.50

9.5

8.1

24.68

24.63

mmol/l

0.08

232

1885

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

637

1.41

2.48

1.7

1.8

187.98

204.12

pmol/l

0.94

612

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

353

0.48

2.48

3.7

2.5

13.48

13.19

0.77

348

(4268621) Lupus anticoagulant assay

218

1.71

2.44

2.5

2.2

—

(3010421) pH of Blood

1040

0.70

2.34

3.6

3.8

7.40

7.41

1.68

1029

(3029937) Albumin [Presence] in Urine by Test strip

799

7279

1.13

2.34

4.0

3.3

0.00

estimate

0.02

235

2533

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

2.83

2.34

1.0

1.1

5.78

9.53

u/ml

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

119

903

1.33

2.33

1.8

1.9

2.01

2.65

ug/l

0.32

105

808

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

133

1.89

2.31

1.1

1.0

300.79

326.79

ng/l

0.23

109

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

105

2.01

2.30

1.1

1.0

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

2.38

2.29

12.0

12.4

0.57

0.66

mmol/l

0.85

(44790048) Parainfluenza type 2 nucleic acid detection

238

1.65

2.28

1.8

1.3

—

(44806118) Parainfluenza type 4 nucleic acid detection

238

1.65

2.28

1.8

1.3

—

(44790047) Parainfluenza type 1 nucleic acid detection

238

1.65

2.28

1.8

1.3

—

(44790049) Parainfluenza type 3 nucleic acid detection

238

1.65

2.28

1.8

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

699

1.37

2.27

3.8

3.0

2.95

2.10

index

0.54

347

(3044009) aPTT.lupus sensitive (LA screen)

4.62

2.27

1.2

1.1

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

2.07

2.27

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

134

1.87

2.26

1.1

1.0

635.84

689.04

ng/l

0.24

103

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

134

1.87

2.26

1.1

1.0

49.95

39.84

ng/l

0.64

109

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.89

2.25

1.0

—

(3014891) Appearance of Pleural fluid

3.11

2.22

1.1

1.3

—

(3008295) Osmolality of Serum or Plasma

240

1.63

2.22

1.3

281.13

277.63

mosm/kgh2o

0.26

198

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

183

1479

1.25

2.22

1.2

209.13

150.79

u/ml

0.48

573

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

295

1.57

2.22

1.1

0.19

2.34

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

157

1.79

2.21

1.1

116.86

104.15

pmol/l

0.51

157

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.34

2.18

1.1

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.24

2.17

2.1

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

346

0.52

2.13

1.4

5.9

9.98

7.38

mmol/l

0.64

299

(3039162) Centromere protein B Ab [Units/volume] in Serum

252

1.59

2.09

1.8

1.2

49.87

48.47

u/ml

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

125

972

1.30

2.09

1.2

1.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1076

10034

1.11

2.06

3.5

3.1

0.02

0.07

estimate

0.64

172

2351

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.51

2.05

1.0

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

635

1.36

2.05

1.3

—

(3016879) Cocaine [Presence] in Urine

391

1.47

2.04

2.2

1.4

—

(3000492) Spirometry study

300

2572

1.18

2.03

1.6

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

602

1.37

2.02

1.6

2.0

2.77

4.08

iu/l

1.60

252

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

3.08

2.01

1.0

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

3.34

1.96

1.6

1.3

1.17

1.18

mmol/l

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

2.57

1.94

1.3

1.1

—

184.33

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

3.75

1.93

1.2

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

2.45

1.93

1.7

14.89

14.38

pmol/l

0.14

(3045142) Bone marrow Pathology biopsy report

266

1.55

1.92

1.1

1.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.19

1.88

1.1

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

407

1.43

1.87

1.2

1.4

50.17

24.94

u/l

0.92

340

(3045788) Cell count panel - Pleural fluid

277

1.52

1.84

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

384

1.44

1.83

1.7

1.6

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.27

1.80

2.2

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.05

1.80

1.0

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

804

7432

1.11

1.79

3.2

2.9

0.01

0.17

estimate

0.84

164

2246

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

505

1.37

1.77

1.3

235.66

217.24

miu/ml

0.13

231

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

570

0.66

1.77

1.3

1.5

—

(1761868) Lipid panel - Serum or Plasma

1101

11693

0.91

1.77

3.2

3.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

329

1.47

1.76

1.1

1.0

4.99

3.95

u/ml

0.15

131

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

136

1096

1.25

1.75

2.7

4.1

29.90

76.50

u/ml

2.59

131

1059

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

1.94

1.74

1.1

1.0

1.06

1.14

u/l

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

110

1.82

1.72

1.0

1409.90

1536.67

miu/ml

0.19

110

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.14

1.71

1.0

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

623

0.69

1.69

2.5

3.2

30.61

29.89

mg/l

0.05

435

(3047181) Lactate [Moles/volume] in Blood

648

1.32

1.69

4.9

5.0

1.50

1.34

mmol/l

0.66

568

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

1.96

1.69

1.3

1.5

105.63

129.71

umol/l

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

259

1.51

1.68

1.5

1.2

0.17

0.18

nmol/l

0.45

192

(21494890) Protein electrophoresis panel - 24 hour Urine

235

1.54

1.67

2.2

1.9

—

(3027944) Amphetamines [Presence] in Urine

426

1.39

1.66

2.2

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.86

1.66

1.6

3.5

1.47

1.36

0.07

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

2.58

1.66

1.6

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

157

1.66

1.65

1.3

1.8

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.03

1.64

1.1

—

(3027008) Opiates [Presence] in Urine

427

1.39

1.64

2.2

1.4

—

(21494755) Public health laboratory ask at order entry panel

239

2772

0.85

1.64

1.4

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

3.58

1.61

1.0

—

(3034426) Prothrombin time (PT)

2.15

1.61

1.3

27.67

28.05

0.08

(4133840) Spirometry

2.00

1.59

1.4

1.1

—

(3028300) Cannabinoids [Presence] in Urine

430

1.38

1.58

2.7

1.4

—

(3047189) Immunofixation for 24 hour Urine

129

1.71

1.56

2.0

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

208

0.48

1.56

1.3

1.5

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

1.89

1.54

1.9

1.4

6077.50

7603.18

e6/l

—

(3000764) Benzodiazepines [Presence] in Urine

424

1.37

1.54

2.2

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

265

1.48

1.53

1.2

1.1

1.60

3.00

eliau/ml

—

143

(3025941) Bacteria identified in Stool by Culture

141

1161

1.22

1.53

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.34

1.52

1.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.60

1.51

3.0

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

205

0.49

1.50

1.3

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.81

1.47

1.5

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.81

1.47

1.5

1.3

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

2.50

1.45

2.3

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

587

1.30

1.42

1.7

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

362

1.39

1.42

1.1

1.0

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

119

1.69

1.37

1.2

1.04

1.07

ratio

0.80

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

119

1.69

1.37

1.1

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

175

1.55

1.34

1.0

1.1

—

(37208534) Antinuclear antibody arbitrary concentration in serum

2.04

1.32

1.0

1.1

—

(3042631) Mycobacterium sp identified in Specimen

392

0.66

1.31

2.0

2.6

—

(3012441) Differential panel - Pleural fluid

317

1.39

1.31

1.3

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

121

1.66

1.30

1.1

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

257

0.58

1.29

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

129

1.63

1.29

1.2

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

219

0.55

1.29

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

259

1.43

1.29

1.4

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.78

1.28

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.40

1.24

1.0

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

538

1.29

1.24

4.6

3.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

131

1.61

1.23

1.7

2.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

330

1.37

1.22

1.1

1.0

0.42

1.03

u/ml

0.63

110

(40757373) Influenza virus identified in Isolate

2.31

1.18

2.8

1.2

—

(3025130) Human papilloma virus identified in Specimen

315

1.37

1.18

2.2

1.9

—

(3029396) Erythrocyte agglutination [Presence] in Blood

2.50

1.15

2.8

2.7

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

1.69

1.13

1.1

1.2

2.80

10.00

u/ml

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

111

1.63

1.12

1.2

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

259

1.39

1.11

4.6

3.3

12.74

12.05

index

0.24

146

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

135

1.56

1.11

2.0

1.2

36.25

22.91

u/l

0.44

119

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

104

1.64

1.09

1.2

1.3

—

1120609.80

—

(3002619) Bacteria identified in Specimen by Culture

1.82

1.09

1.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

585

1.25

1.08

1.6

1.5

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.19

1.08

1.1

1.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.65

1.06

2.1

1.7

97.75

126.14

ng/l

0.70

(3020650) Glucose [Presence] in Urine

124

0.48

1.04

1.2

1.6

0.00

0.03

estimate

—

124

(3003434) Protein [Mass/volume] in Pleural fluid

402

1.30

1.03

1.3

1.4

32.54

33.18

g/l

0.13

364

(3034274) Bile acid [Moles/volume] in Serum --fasting

130

1.54

1.02

1.5

1.7

17.97

5.78

umol/l

0.44

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

257

1.37

0.98

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.18

0.98

1.0

1.7

16.80

16.84

umol/l

—

(3050794) Legionella sp Ab [Presence] in Serum

2.18

0.98

1.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

181

1.44

0.98

1.2

1.1

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

164

1869

0.87

0.97

2.7

2.5

66.59

68.94

ml/min/173m2

0.40

830

(3025018) Bordetella pertussis Ab [Titer] in Serum

140

1.50

0.97

1.0

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

1.85

0.96

4.4

7.6

8.71

8.72

mmol/l

—

(3026389) Candida sp identified in Specimen by Organism specific culture

241

1.37

0.96

1.5

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

199

1.41

0.95

6.6

6.4

563.84

65.20

u/ml

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

216

1.39

0.95

1.1

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.69

0.95

1.1

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.78

0.94

1.1

1.0

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

1.89

0.94

1.0

1.1

6.08

8.98

mg/g

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.22

0.93

1.0

—

(40768441) Liver Pathology biopsy report

175

1.43

0.92

2.0

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

151

1.46

0.90

1.0

1.1

6.21

13.62

iu/ml

—

(3044941) Cell count panel - Synovial fluid

447

1.26

0.90

1.5

1.4

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.07

0.89

1.5

1.3

58.70

49.55

mg/l

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.07

0.89

12.0

9.9

5.65

5.73

mmol/l

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

194

1.40

0.88

2.4

1.4

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

934

0.83

0.87

1.1

1.2

0.66

0.60

ratio

0.45

178

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.86

0.87

2.6

2.2

4.13

11.49

ug/l

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

213

1.36

0.84

1.4

1.6

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

1.59

0.84

1.1

97.44

92.17

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.78

0.84

1.1

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

106

910

1.17

0.84

1.5

1.8

5.05

4.29

mg/l

0.20

653

(40765096) Chromosome analysis panel by Banding

1.76

0.83

1.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

154

1.43

0.83

1.2

1.1

23.15

19.36

u/ml

0.12

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

121

1.49

0.82

1.2

1.6

3.85

4.23

ug/l

0.09

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.88

0.81

1.2

1.7

—

(3000012) Reticulocyte production index

432

0.76

0.81

2.3

1.21

0.86

1.27

279

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

427

1.25

0.81

1.7

1.6

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

410

1.25

0.79

1.2

—

1.04

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.73

0.79

1.1

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.00

0.79

0.0

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

375

1.26

0.78

1.2

—

(3020891) Body temperature

127

1113

1.15

0.78

5.2

4.7

36.93

36.90

°c

0.47

127

1106

(3034891) Synovial lining cells/cells in Synovial fluid

131

1.45

0.78

1.5

—

4.87

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.77

0.0

2.7

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.77

0.76

1.7

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.70

0.75

1.4

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

183

1.37

0.75

1.2

1.3

12.08

12.17

u/l

0.03

177

(3010726) Horse dander IgE Ab [Units/volume] in Serum

306

1.28

0.75

1.1

1.0

0.64

0.77

u/ml

0.09

109

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

2.09

0.74

1.0

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

298

1.28

0.73

1.0

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.84

0.73

1.0

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1222

11837

1.05

0.73

2.0

1.9

1.35

1.36

mmol/l

0.09

1062

9650

(3024869) Neuronal Ab [Presence] in Serum

1.80

0.72

1.0

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

654

1.18

0.72

1.7

1.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

398

1.23

0.71

1.2

1.1

2.24

1.86

u/ml

0.11

183

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

117

1.46

0.71

1.3

1.4

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

988

0.86

0.71

1.1

1.2

1.50

1.53

g/l

0.54

988

(3003329) Lymphocytes/Leukocytes in Synovial fluid

247

1.30

0.70

1.4

1.5

24.95

32.83

0.56

147

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

247

1.30

0.70

1.1

1.0

0.02

0.23

u/ml

—

(3020491) Glucose [Moles/volume] in Blood

160

1.38

0.70

1.2

1.8

6.30

6.97

mmol/l

1.14

125

(4198724) Urine methamphetamine measurement

1.71

0.70

1.3

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.71

0.70

1.1

2.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.51

0.69

1.4

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.60

0.68

1.3

1.1

—

(3023419) Bacteria identified in Sputum by Culture

320

1.25

0.67

3.6

2.0

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

407

0.78

0.67

1.3

1.4

—

(3046861) Legionella sp Ag [Presence] in Urine

0.00

0.60

0.0

1.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.00

0.60

0.0

1.1

—

24.75

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

131

1.38

0.59

1.0

0.64

0.49

u/ml

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.56

0.58

1.1

1.2

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.00

0.58

0.0

1.3

—

3051.00

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

215

1987

1.09

0.56

1.3

—

(3052592) Norovirus Ag [Presence] in Stool

1.67

0.56

1.2

1.4

—

(21494814) CD8 cells/Lymphocytes in Specimen

1.45

0.55

2.0

30.15

30.94

0.11

(3014133) Dog dander IgE Ab [Units/volume] in Serum

284

1.24

0.55

1.1

1.0

1.96

1.81

u/ml

0.06

101

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

373

0.80

0.55

2.1

1.4

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

186

1.29

0.54

1.2

—

104.00

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

186

1.29

0.54

1.2

355.00

218.00

titre

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

297

3162

0.93

0.54

2.1

2.2

3.53

3.44

ratio

0.60

248

2579

(3044007) Cell count panel - Peritoneal fluid

1.43

0.53

2.4

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.41

0.51

1.1

—

(4062490) Immunoglobulin typing, IgG

188

1.28

0.51

1.9

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

233

1.25

0.51

1.3

—

(3020874) Milk IgE Ab [Units/volume] in Serum

127

1.34

0.49

1.0

1.1

3.20

1.32

u/ml

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.52

0.48

1.0

1.1

8.14

37.51

iu/ml

—

(4034850) Laboratory test

104

1152

0.90

0.48

6.7

8.7

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.47

0.47

2.2

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.40

0.45

1.0

1.5

12.26

8.69

ug/l

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

129

0.70

0.43

4.3

3.9

—

(4281824) Cell count and differential, peritoneal fluid

304

1.19

0.42

1.3

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.47

0.40

1.2

1.3

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.00

0.40

0.0

1.1

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.34

0.39

1.1

1.0

158.19

185.76

iu/ml

0.23

(3016650) Hepatitis A virus Ab [Presence] in Serum

391

1.15

0.38

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

142

1.27

0.38

1.6

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.39

0.38

1.0

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

119

1289

0.92

0.38

1.8

1.7

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

206

1.22

0.38

1.3

1.4

142.28

163.58

pmol/l

0.39

206

(40760892) CBC W Ordered Manual Differential panel - Blood

582

5633

1.04

0.38

4.7

4.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

244

1.19

0.36

1.1

1.5

0.50

0.29

nmol/l

0.84

176

(1617658) Protocol used for examination of sentinel lymph nodes

180

1.22

0.36

1.1

—

(3006270) Folate [Moles/volume] in Blood

162

1.24

0.35

1.1

368.77

407.28

nmol/l

0.27

144

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

227

1.19

0.34

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

154

1.24

0.34

1.2

0.07

1.43

u/ml

1.48

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.30

0.33

1.0

1.4

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.33

0.32

1.5

1.2

98.64

169.13

mmol/24h

1.86

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

560

1.11

0.31

2.4

89.69

90.46

ug/min

0.01

358

(3023430) Cat dander IgE Ab [Units/volume] in Serum

277

1.16

0.30

1.1

1.0

2.78

3.44

u/ml

0.12

(3008898) HLA-B27 [Presence]

687

1.09

0.30

1.1

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

174

0.80

0.29

1.3

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

477

1.11

0.29

1.5

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

563

1.10

0.29

1.5

1.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

194

1.19

0.29

1.0

1.1

—

(4211845) Urine protein measurement

112

1.25

0.28

2.3

2.4

—

(3006462) Nitrate [Presence] in Urine

103

1.26

0.28

2.4

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.25

0.27

1.8

1.4

56.38

159.70

nmol/24h

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

131

1.22

0.27

1.0

1.2

8.94

11.28

mm/h

0.51

131

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

150

0.80

0.27

1.5

1.6

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

141

1.21

0.26

7.6

7.9

1.48

43.70

ug/l

1.15

102

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

224

0.85

0.25

1.5

0.88

1.12

ratio

0.72

138

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

224

0.85

0.25

1.5

1.08

1.19

ratio

0.14

138

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

224

0.85

0.25

1.5

1.03

0.99

ratio

0.23

138

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

1.18

0.24

3.9

2.7

33.11

28.83

umol/l

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

599

1.09

0.24

1.3

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

735

1.08

0.24

1.4

1.3

33.24

36.44

iu/l

0.31

622

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.77

0.22

1.0

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

221

0.86

0.22

1.5

—

(3016750) Collection duration of Urine

135

0.81

0.22

2.1

2.3

510.36

503.71

min

0.09

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

84.30

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.21

0.0

1.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.21

0.0

1.3

—

1.29

—

(3045462) Protein/Creatinine [Ratio] in Urine

0.00

0.21

0.0

5.3

—

21.58

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.3

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

258

1.13

0.21

1.5

1.3

—

nmol/l

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1017

0.94

0.21

1.4

1.2

0.93

0.89

g/l

0.75

1012

(3035082) Kappa light chains [Mass/volume] in Urine

0.00

0.21

0.0

1.2

—

0.02

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.20

0.0

2.6

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1.22

0.20

1.8

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

385

0.91

0.19

1.5

1.6

1024.28

963.47

mu/l

0.17

312

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.15

0.19

1.2

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

533

5230

1.02

0.18

1.7

83716028.08

31933582.06

pmol/l

0.84

436

4309

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

1.22

0.17

1.6

2.3

194.90

143.51

nmol/l

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.75

0.17

23.2

6.2

5.69

6.07

kpa

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.11

0.16

1.1

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.75

0.15

1.0

1.4

—

(40768795) Lymph node Pathology biopsy report

274

1.10

0.15

1.4

1.2

—

(40768806) Pleura Pathology biopsy report

332

1.09

0.15

1.6

1.5

—

(3025577) Chromium [Mass/volume] in Blood

150

1.13

0.14

2.4

2.2

2.48

2.63

ug/l

0.08

129

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

128

0.86

0.13

1.5

84.79

54.58

ug/l

0.63

128

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

354

1.07

0.13

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

113

1.15

0.13

1.1

1.0

—

(40768793) Breast Pathology biopsy report

512

1.06

0.12

1.5

1.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

114

1.14

0.11

1.0

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

199

0.90

0.11

1.6

—

(3020961) Endomysium IgA Ab [Titer] in Serum

928

1.04

0.10

1.1

—

143.60

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

197

0.91

0.10

1.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.82

0.08

1.0

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.83

0.08

23.2

6.2

5.72

5.06

kpa

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

222

2183

1.02

0.08

1.7

1.8

3.43

3.46

mmol/l

0.11

168

1565

(3050129) First trimester maternal screen panel - Serum or Plasma

246

0.93

0.08

1.6

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

133

0.90

0.07

1.0

1.1

—

(3005033) Fetal Nuchal fold Thickness US

194

0.93

0.07

1.5

1.53

1.32

—

135

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

328

1.04

0.04

1.9

1.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

102

1.08

0.03

1.3

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

478

0.98

0.01

1.3

1.4

—

(1002224) Polysomnography panel

125

1259

0.99

0.01

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

135

1.04

0.00

1.3

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

131

0.99

0.00

1.2

2.6

8.10

8.18

mmol/l

0.03

131

(44813793) Dust mix specific IgE antibody measurement

149

1.01

0.00

1.2

1.1

—

(3004451) EKG impression Narrative

164

0.98

0.00

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

406

1.01

0.00

1.1

—

(3017569) Oxygen content in Arterial blood

142

0.99

0.00

1.2

2.7

17.14

15.82

0.98

142

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

182

0.99

0.00

1.2

1.8

0.92

1.44

u/field

0.68

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

282

0.99

0.00

1.2

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

407

1.01

0.00

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

647

1.00

0.00

2.3

2.4

129.36

130.03

g/l

0.07

523

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

26.88

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.7

—

243.72

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

6.6

—

1.37

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

0.00

0.0

8.0

—

0.48

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.2

—

28.34

—

(3006576) Bicarbonate [Moles/volume] in Blood

0.99

0.00

5.0

6.4

25.54

24.80

mmol/l

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.0

—

2.20

—

(3013762) Body weight Measured

0.00

0.0

1.7

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

0.05

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

0.98

-0.00

1.6

1.3

—

0.33

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.95

-0.00

2.1

4.26

4.89

kpa

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.95

-0.00

2.1

10.89

10.02

kpa

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

1.22

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.00

-0.00

1.2

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: Z21_SPECIAL_SCREEN_EXAM_NEOPLASMS – Special screening examination for neoplasms

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Special screening examination for neoplasms

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Special screening examination for neoplasms (Z21_SPECIAL_SCREEN_EXAM_NEOPLASMS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints